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RESUMEN 
Modulación del transcriptoma inmune de trucha por la proteína no viriónica (NV)  
del Virus de la Hemorragia Septicémica Viral (VHSV).                                                      
Nuevos hallazgos que correlacionan la secuencia de NV con su función. 
 
El género Novirhabdovirus pertenece a familia Rhabdoviridae, y está formado por cuatro 
especies (VHSV, IHNV, HIRRV y SHRV) que infectan exclusivamente peces y se caracterizan por 
la presencia de un gen adicional, que codifica para una proteína no viriónica (NV) que da nombre 
al género. El virus de la septicemia hemorrágica viral (VHSV) tiene gran importancia para la 
acuicultura mundial debido al amplio y creciente rango de hospedadores que infecta, siendo la 
trucha arcoíris uno de los principales hospedadores del continente europeo, pero también 
porque su presencia es considerada de declaración obligatoria para la Organización Mundial de 
Sanidad Animal (OIE). 
El gen NV no tiene similitud con ningún otro conocido hasta el momento y las proteínas 
NV presentan una alta homología dentro de una misma especie pero muy reducida entre 
especies diferentes. A pesar de ello, las proteínas NV de IHNV y de VHSV comparten una función 
similar, siendo ambas prescindibles pero necesarias para una eficiente replicación viral in vitro 
y esenciales para la patogenicidad in vivo de los novirhabdovirus. El efecto de ambas proteínas 
NV se ha relacionado in vitro e in vivo con una menor respuesta antiviral celular. Sin embargo, 
hasta ahora no se conocían en detalle los genes y mecanismos de respuesta inmune modulados 
por la NV, y tampoco la implicación de la estructura en su función. En base a lo expuesto, esta 
tesis planteó como principales objetivos: 1) caracterizar por primera vez el transcriptoma 
inmune de trucha inducido por la NV recombinante de VHSV, sin la interferencia de otras 
proteínas del virus, y 2) delimitar las regiones implicadas en la función, y explicar la aportación 
que tienen algunos aminoácidos de estas regiones en la misma. 
Para ello, previamente se obtuvo la proteína recombinante NV de VHSV (07.71) y se 
inoculó intraperitonealmente en truchas y, posteriormente, se analizó el conjunto de RNAs 
procedentes del bazo y riñón cefálico de cada trucha. El perfil transcriptómico se determinó 
mediante un microarray enriquecido en genes de respuesta inmune, diseñado y validado en el 
laboratorio. Los resultados mostraron que la gran mayoría de los genes estudiados tenían una 
regulación negativa y su implicación era desconocida hasta el momento. Entre los genes 
regulados a la baja se encuentran interferones, factores de necrosis tumoral, genes inducidos 
por VHSV (VIG), interleuquinas, citoquinas, complemento, factores de transcripción y genes de 
procesamiento y presentación antigénica. Además, entre los genes que participan en mayor 
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número de vías de activación (genes multipath) se encuentran factores de transcripción como 
stat1, jun, y atf1; y genes relacionados con interferones y factores de necrosis tumoral. Esto 
explicaría por qué hay una activación deficiente de las vías de señalización implicadas, que a su 
vez conllevaría la baja expresión de otros genes de respuesta inmune relacionados. Así, la 
proteína NV inhibe la respuesta inmune innata y adaptativa humoral y celular, interfiriendo con 
la respuesta antiviral temprana del hospedador. 
Por otro lado, el mapeo funcional de la NV se llevó a cabo con 8 fragmentos de la 
proteína NV de VHSV (F1 a F8) midiendo la inhibición de la expresión de transcritos de mx e il8 
en células de pez cebra (ZF4) transfectadas. El fragmento N-terminal más completo de la NV (F1) 
inhibió mx e il8 de manera similar a la NV completa, mientras que el fragmento C-terminal F2 
perdió la función original de la NV. Otros fragmentos N-terminales más pequeños conservaron 
también la función, aunque incluyeran parte de la secuencia C-terminal, sugiriendo que la parte 
N-terminal es más importante que la C-terminal para la función. Para llevar a cabo una 
caracterización funcional más completa de la NV, también generamos 11 variantes de la 
proteína en las posiciones 28, 31, y de la 33 a la 41. Mientras algunas variantes conservaron o 
perdieron ligeramente la función, las variantes NVD36A, NVR39A y NVD41A incrementaron 
significativamente su capacidad de inhibición de mx e il8 en células ZF4. Todas las proteínas NV 
completas, nativas y variantes, presentaron la misma localización citosólica perinuclear de 
aspecto punteado. Además, los fragmentos N-terminal de la NV también presentaron la misma 
localización citosólica mientras que el fragmento C-terminal, no funcional (F2), estaba 
difusamente distribuido en la célula. Esto sugiere que la localización está correlacionada con la 
función, y la función con la parte N-terminal de NV. Recientemente se ha caracterizado un 
ligando de NV, PPM1Bb, capaz de defosforilar TBK1 e interferir posteriormente con la respuesta 
de RIG-I. Las variantes NVD36A, NVR39A, y NVD41A, por su parte, serían más efectivas en la 
estabilización de PPM1Bb y posterior defosforilación de TBK1, resultando en una mayor 
downregulación de mx e il8. Así, los resultados del perfil transcriptómico de trucha inducidos 
por la NV permiten conocer mejor el modelo de infección por VHSV y los procesos de 
estimulación-inhibición de vías de señalización de la respuesta inmune frente a rhabdovirus. 
Finalmente, el desarrollo de una técnica de detección semi-automática de anticuerpos 
neutralizantes frente a VHSV en pequeños volúmenes de plasma permitiría su aplicación al 
estudio de la efectividad de las vacunas frente al virus, particularmente aquellas basadas en la 
deleción de la NV. 
 
Palabras clave: Trucha, VHSV, NV, transcriptoma, inhibición de la respuesta inmune.
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SUMMARY 
Immune transcriptome modulation in trout by the non-virion (NV) protein               
from Viral Haemorrhagic Septicaemia Virus (VHSV).                                                                           
New insights correlating the NV sequence with function. 
 
Novirhabdovirus genus belongs to the family Rhabdoviridae, and it consists of four 
species (VHSV, IHNV, HIRR and SHRV) that exclusively infect fish and are characterized by the 
presence of an additional gene encoding a non-virion (NV) protein that gives name to the genus. 
Viral haemorrhagic septicaemia virus (VHSV) is of great importance for global aquaculture due 
to the wide and growing range of hosts it infects, being rainbow trout one of the main hosts of 
the European continent, but also because its presence is considered of mandatory notification 
to the World Organization for Animal Health (OIE). 
The NV gene has no similarity to any other known gene so far and NV proteins show high 
homology intra-species but very low inter-species. In spite of this, NV proteins of IHNV and VHSV 
share a similar function; they both are dispensable but necessary for an efficient viral replication 
in vitro and essential for in vivo pathogenicity of the novirhabdoviruses. The effect of both NV 
proteins has been linked in vitro and in vivo with a lower cell antiviral response. However, genes 
and immune response mechanisms modulated by NV were not known in detail until now, nor 
was the relationship between the structure and function. On the basis of the above, this thesis 
proposed as main objectives: 1) to characterize for the first time the immune-related 
transcriptome of trout induced by recombinant NV of VHSV, without the interference of other 
viral proteins, and 2) to define the regions involved in the function, and to explain the 
contribution of some amino acids from these regions to the function. 
For that purpose, recombinant VHSV NV protein (07.71) was previously obtained and 
intraperitoneally injected into trouts and subsequently the RNA pool of the spleen and head 
kidney of each trout was analysed. The transcriptome profile was determined by using an 
enriched microarray of immune response genes, designed and validated by the laboratory. The 
results showed that the great majority of the genes studied were down-regulated and their 
involvement was unknown until now. Among these down-regulated genes are interferons, 
tumor necrosis factors, genes induced by VHSV (VIG), interleukins, cytokines, complement, 
transcription factors and genes for antigenic processing and presentation. Moreover, among the 
genes involved in a greater number of activation pathways (multipath genes) are transcription 
factors such as stat1, jun, and atf1; and genes related to interferons and tumor necrosis factors. 
This would explain why there is a poor activation of the signaling pathways involved that would 
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in turn lead to low expression of other immune-related genes. Thus, NV protein inhibits both 
humoral and cellular processes of innate and adaptive immune responses, interfering with early 
antiviral response of the host. 
On the other hand, the NV functional mapping was performed with 8 fragments of the 
VHSV NV protein (F1 to F8) by measuring the inhibition of the expression of mx and il8 transcripts 
in transfected zebrafish (ZF4) cells. The most complete N-terminal fragment of NV (F1) inhibited 
mx and il8 similarly to whole NV whereas the C-terminal fragment F2 lost NV original function. 
Other smaller N-terminal fragments also retained function, even if they included part of the C-
terminal sequence, suggesting that the N-terminal part is more important than the C-terminal 
for the function. To carry out a more complete functional characterization of NV, we also 
generated 11 variants of the protein in positions 28, 31, and 33 to 41. While some variants 
conserved or slightly lost function, variants NVD36A, NVR39A and NVD41A increased 
significantly its ability to inhibit mx and il8 in ZF4 cells. All complete NV proteins, native and 
variants, presented the same cytosolic location with a perinuclear dotted appearance. In 
addition, the N-terminal fragments of NV also showed the same cytosolic location while the non-
functional C-terminal fragment (F2) was diffusely distributed within the cell. This suggests that 
the location is correlated with the function, and in turn, the function with the N-terminal part of 
NV. Recently, it has been described a ligand of NV, PPM1Bb, capable of dephosphorylating TBK1 
and subsequently interfering with the response of RIG-I. The variants NVD36A, NVR39A, and 
NVD41A, for their part, would be more effective in stabilizing PPM1Bb and further 
dephosphorylation of TBK1, thus resulting in a greater downregulation of mx and il8. Thus, the 
results of the trout transcriptomic profile induced by NV allow for better understanding of VHSV 
infection model and the processes of stimulation-inhibition of immune signaling pathways 
against rhabdoviruses. 
Finally, the development of a semi-automatic assay to detect anti-VHSV neutralizing 
antibodies in low volumes of plasma blood samples could allow its application in future studies 
on vaccine effectiveness, particularly those based on NV deletion. 
 
Keywords: Trout, VHSV, NV, transcriptome, inhibition of immune response. 
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Introduction 
 
 
3 
A. VIRAL HAEMORRHAGIC SEPTICAEMIA (VHS) DISEASE 
1. Importance of VHS disease  
Aquaculture broadly refers to the farming of aquatic organisms, including finfish, shellfish, 
crustaceans and plants, primarily for human consumption, and has been practiced since 
antiquity. However, it was not until the mid-20th century that intensive, industrial-scale 
aquaculture became viable, and recent decades have witnessed a dramatic expansion such that 
it is currently the fastest growing food producing sector globally [1]. In a world where more than 
800 million people continue to suffer from chronic malnourishment [2], and where the global 
population is expected to grow and reach 9.6 billion people by 2050, aquaculture plays an 
increasingly critical role in global food security. Four decades ago, aquaculture accounted for 
only 7% of all fish consumed globally, with the vast majority being produced by the capture 
sector [3]. However, a milestone was reached in 2014, when for the first time, aquaculture 
accounted for the majority of fish consumed globally [4]. 
The development of large-scale intensive aquaculture has been associated with a dramatic 
increase in severe disease outbreaks caused by a diverse range of pathogens, including 
parasites, viruses and bacteria [5]. These disease outbreaks can be catastrophic for the industry 
and are especially relevant for the World Organisation for Animal Health (OIE) notifiable 
pathogen species, the presence of which may incur the destruction of stock or a temporary ban 
on trading between states [6]. 
Viral haemorrhagic septicaemia (VHS) is one of the most serious viral diseases of the 
aquaculture industry worldwide. A notable characteristic and part of the reason for the 
importance of this virus in so many countries in the world is the very large and continually 
increasing number of fish species that can be infected with clinical consequences and high 
mortality rates [7]. This is in direct contrast to the very similar virus, IHNV (most recently 
renamed as Salmonid novirhabdovirus), the impacts of which are largely restricted to salmonids 
[8]. 
Historically, European rainbow trout production has been threatened by viral haemorrhagic 
septicaemia (VHS), which annually leads to substantial economic losses in the trout farming 
industry. The annual losses of rainbow trout in Europe since the first appearance of VHSV on fish 
farms have been estimated to exceed 40 million pounds per year [9]; however, the true 
economic cost of VHS is not well characterized. These losses can be a direct consequence of fish 
mortality or an indirect consequence of disease control measures. 
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Due to its high mortality and large economic impact, VHS is classified as a notifiable disease 
by the World Organization for Animal Health (OIE) [10] and the European Union (Council 
Directive 2006/88/EC) [11]. For all the reasons mentioned above, VHS remains one of the most 
important diseases of finfish worldwide. 
2. Host factors and disease pattern  
Infection with VHSV may cause disease and mortality in all life stages of susceptible fish. 
However, VHSV is not known to infect fish eggs, which can carry the virus externally without 
being affected [12, 13]. On the other hand, several factors influence susceptibility to VHS 
disease. In rainbow trout there is genetic variability for susceptibility [5], and the age of the fish 
appears to be of some importance. In general, the disease is more abundant in populations of 
young, not previously infected fish (the younger the fish the higher the susceptibility) [14]. 
The virus usually causes a severe disease with mortality rates as high as 100% in fry, but 
ranges from 5% to 90% in older rainbow trout. During acute VHS infection, fish do exhibit 
external disease signs such as skin darkening, exophthalmia (bulging eyes), internal and external 
haemorrhages on the skin, gills, eyes, and internal organs (mainly in kidney and liver), ascites 
(bloated abdomens) and/or erratic swimming behaviour (Figure 1). However, varied forms of 
disease have been described for VHS (acute, chronic and nervous) in rainbow trout 
(Oncorhynchus mykiss) [15], and a persistent infection/asymptomatic carrier state for VHSV has 
also been reported being often associated with neural tissues. Therefore, it has been proposed 
that the brain offers the potential for virus to persist and escape immunodetection, and this may 
have significant implications in the maintenance of viral reservoirs in wild fish [16-21]. 
VHS is commonly a cool- or cold-water disease that is most prevalent and readily transmitted 
when fish congregate during the spring spawning season at temperatures of 9–12°C [22-24]. Its 
viral particles can live for up to 13 days in the water, depending upon temperature [25], and are 
transmitted from fish to fish (horizontal transmission) through contact with the urine and 
reproductive fluids of other infected fish and also via shed mucus [22, 26, 27], through virus-
contaminated water or objects (ballast water and boating, fishing tackle) [27, 28] and diverse 
vectors including amphipod crustaceans (Diporeia spp) [29], leeches [30], freshwater turtles 
[31], and piscivorous birds [32, 33]. However, the movement of infected fish, for example 
baitfish [34-36], represents a risk factor for introducing VHSV to new areas. 
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Figure 1. Clinical signs of VHSV infection. (a) Lake trout (Salvelinus namaycush) showing moderate 
exophthalmia, (b) severe gill pallor (c), hemorrhaging at the base of the dorsal fin of a juvenile 
muskellunge (d), and petechial hemorrhages in the epidermis of a splake (Salvelinus namaycush · S. 
fontinalis). Figure obtained from Kim and Faisal 2011 [27]. 
 
With regard to viral entry, the main route is suggested to be the skin and/or gills [37], being 
the fin bases more important than the gills in rainbow trout [38-40]. Recently, vaccination 
studies showed that the virus can have an entry route through the gut epithelial layer [41, 42] 
and this oral transmission route has been demonstrated for rainbow trout [43] and tiger 
muskellunge (Esox lucius × E. masquinongy) [34] through food-borne, water-borne and 
cohabitation infections. 
3. VHS etiology and history 
The disease was first recognized as early as 1938 when Danish rainbow trout farms became 
stricken with what Schäperclaus described as “infectious kidney swelling and liver degeneration” 
[44]. Even though a viral etiology was early suspected by Schäperclaus because the disease was 
transmitted using bacteria-free filtrates of tissue homogenates from affected fish, the viral 
etiology was not confirmed until 1963, when Jensen isolated the virus on a rainbow trout gonad 
cell line (RTG-2) and promptly described it as “Egtved” virus [45]. The disease was later renamed 
as Viral Haemorrhagic Septicaemia by the Office of International Epizooties (currently known as 
the World Animal Health Organization) and this terminology remained until 2000 when the 
International Committee for Taxonomy of Viruses (ICTV) changed the name of the virus into 
VHSV [46].  
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Until the late 1980s, VHSV was thought to be strictly a disease of farmed rainbow trout 
(Oncorhynchus mykiss) of freshwater in Europe; and further typing of those European strains 
showed that they all were within genotype Ia [47]. However, the detection of VHSV in returning 
adult Chinook and Coho salmon in North America in 1988, later defined as genotype IVa, 
confirmed the expansion of VHSV range to that continent [48, 49]. 
The following years (1990-1999), new more VHSV isolations occurred in North America, 
causing fatal disease in fish from marine and brackish environments of Washington and Alaska, 
and also other fish species were found affected (e.g.: Pacific cod, Pacific herring, etc.) [26], 
providing evidence that VHSV was more widespread in the marine environment than previously 
thought. Such discoveries in the coastal waters of Alaska and the Pacific Northwest led to a study 
conducted by Hedrick et al. 2003 [50], which revealed the presence of VHSV in new hosts 
(sardine, mackerel and 2 species of smelt) and extended the geographic range (Oregon and 
California, USA). 
During this same time frame, VHSV continued to devastate freshwater and marine waters 
in Europe and simultaneous reports of VHSV outbreaks were described. Moreover, the North 
American VHSV isolations ignited further testing of marine fish populations in European waters. 
Later identification of VHSV (genotypes I to III) in a vast number of marine fish species in Europe 
[51] raised the suspicion that VHSV was of marine origin and investigations into the source of 
the trout-pathogenic European genotype Ia isolate showed that it likely emerged from a marine 
source some 60 years earlier [47]. In addition to Europe and North America, VHSV has also been 
isolated in Japan from wild Japanese flounder (Paralichthys olivaceus) in 1999 and in Korea [52-
54]. Based on the information gathered from all over the world, by the late 1990s, a consensus 
started building that VHSV primarily affects marine fish and that VHSV may have a marine origin 
[55].  
The expansive and highly adaptable nature of VHSV was clearly underestimated after being 
isolated from adult muskellunge sampled from Lake St. Clair, Michigan between 2003 and 2005 
[56], at which time no other rhabdoviruses were known to infect any fish species in the Great 
Lakes Basin. Currently, the VHSV-related events in the Great Lakes Basin have emphasized the 
need to study the origin of VHSV and its ability to devastate fishes in both the freshwater and 
marine environments and the path it takes to spread.  
More recently VHSV was isolated from rainbow trout in the United Kingdom [57]. While this 
resurgence of VHSV in Europe is not surprising, the isolation reported by Stone et al. 2008 [57] 
demonstrated the first VHSV isolation in the United Kingdom (UK) obtained from a freshwater 
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species in a freshwater environment. The investigators attributed the outbreak to a nearby 
stream that may have been harboring the virus for a long period of time.  
Taken together, these results emphasized the fact that while legislation, biosecurity, and 
sound management practices can greatly reduce the spread of VHSV, the virus’ covert nature 
enables it to continue expanding into new geographic locations. The re-emergence of VHSV was 
also experienced in Norway in seawater-farmed rainbow trout [58]. The authors concluded that 
the outbreak was most likely a result of viral transmission from the marine environment. Both 
isolations have thus confirmed VHSV’s capacity to emerge and resurge in the northern 
hemisphere. 
4. Control and prevention: vaccination  
“Prevention is better than cure” is a well-known expression in human as well as veterinary 
medicine. Preventive measures are especially important in aquaculture where the number of 
individuals at risk is high, pathogenic microorganisms may be transmitted through water (which 
disinfection is difficult or even impossible) and where chemotherapy is a challenge from 
practical, technical, economic and environmental points of view [59]. 
Prevention and control of infectious disease by fish vaccination is becoming increasingly 
important as a part of aquaculture biosecurity. Vaccination has a positive effect on fish farming 
and the aquaculture industry by reducing morbidity, mortality and the costs of therapy, and by 
improving product quality. Vaccination may also improve animal welfare by reducing the 
suffering of diseased fish. Moreover, vaccinated animals have a reduced risk of disease 
development and even non-vaccinated animals may be protected due to herd immunity [60]. 
Finally, prophylaxis based on stimulation of the immune system also contributes to a sustainable 
aquaculture with low use of antibiotics [59]. 
Although research on vaccine development for VHS has been ongoing for more than four 
decades, a commercial vaccine against VHS is not yet available. Several candidate vaccines have 
been tested to control this disease, among them live attenuated vaccines [61-63], inactivated 
vaccines [64-66] and recombinant protein vaccines [67-69] but with limited efficacy or 
compromised safety aspects and also difficulties associated with the requirement for large-scale 
production and mass delivery system for vaccination [65, 70, 71] (see Table 1 for a comparative 
analysis). 
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A recent alternative approach to engineer new and possible safer live attenuated vaccines, 
including knockouts, is based on reverse genetics (see NV role section of thesis) [72-75]. 
Moreover, recombinant viruses recovered by reverse genetics can be engineered as “DIVA” 
(differentiating between infected and vaccinated animals) vaccines, thus allowing easy 
discrimination between vaccinated and naturally-infected fish in the field [76]. However, 
additional work is needed to improve the safety of such vaccines [77]. 
By contrast, DNA vaccines have shown promising results. DNA vaccines containing the G 
gene of VHSV were first reported to be protective in 1998 [78]. Since then, several VHSV DNA 
vaccines have been developed and tested in numerous experimental trials and they have been 
shown to be highly efficacious in inducing specific and protective immunity under a wide range 
of conditions and in several marine and freshwater fish species (for review see [77, 79]). In 
addition to the European freshwater VHSV DNA vaccines, there is now a DNA vaccine against a 
marine strain of VHSV that has shown high efficacy in flounder [80, 81]. The success of these 
vaccines led to the licensing and commercialization of a DNA vaccine against a related 
novirhabdovirus, IHNV, for Atlantic salmon (APEX-IHN; Novartis Animal Health Canada Inc.) in 
Canada in 2005, with no outbreaks reported since [82]. Nevertheless, safety considerations have 
not allowed yet their commercialization in Europe (DNA-vaccinated fish are considered as 
genetically modified organisms) and a mass delivery system for vaccination of fish fry is required. 
However, their efficacy varies with the relatedness of the challenge strain to the strain used to 
create the vaccine [83]. The majority of publications using these vaccines describe homologous 
challenges, but it has also been tested for efficacy against heterologous VHSV strains [84], 
providing significant protection but with reduced efficacy compared to the homologous virus 
strain (54 to 78 relative percent survival (RPS) compared to 77 to 100 RPS). Moreover, dual 
vaccination assays with both VHSV and IHNV DNA vaccines have been shown to induce 
neutralizing antibodies specific to both viruses and protect fish against coinfection [85-87]. 
Although DNA vaccines seem to be effective, well tolerated and safe for fish, several aspects 
need to be improved, such as the route of delivery to allow mass immunization and safety 
concerns (DNA persistence, environmental release, etc.) [77]. 
Since no cross-protection exists between VHSV and IHNV, an efficient vaccine against VHSV 
is still required. Meanwhile, control of VHSV in the absence of any treatment (and taking into 
account the difficulties in treating fish infected) and commercial vaccines, is achieved by 
prevention of introduction and eradication by stamping-out in case of disease outbreaks. This is 
the case of Denmark, which through a permanent surveillance and control program, has been 
declared VHS-free and no new outbreak was recorded for more than two years [88].  
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  Table 1. Advantages and disadvantages of VHSV vaccines (reviewed from [71, 77]). 
VHS Vaccines 
Types Description Advantages Disadvantages 
Replicating vaccines 
(Live-attenuated vaccines) 
Attenuation is obtained through multiple 
passages of VHSV on cell culture, 
neutralization escape mutants and 
thermoresistant viruses. Currently, 
attenuation is also obtained by reverse 
genetics.  
High levels of protection by bath 
immersion and oral delivery. 
Attenuated viruses by reverse genetics 
allow discrimination between vaccinated 
and naturally-infected fish (DIVA) and they 
could be used as safe live-attenuated 
vaccines. 
Differences in fish disease susceptibility and safety 
problems (residual virulence was observed in most 
cases). 
Non-replicating 
vaccines 
 
Inactivated 
vaccines 
Inactivation of whole virus can be easily 
achieved either by chemical (e.g. β-
propiolactone) or physical (e.g.UV) 
treatment. 
Efficient in inducing long-term protection 
when delivered by intraperitoneal injection 
and do not require the use of adjuvants. 
Protection was not sufficient by bath immersion 
challenge and, for this reason, are not suitable for 
mass delivery in young fish. 
An additional concern is the loss of immunogenicity 
during the inactivation process. 
Subunit 
vaccines 
VHSV subunit vaccines are based on the 
recombinant G protein, the unique 
target of neutralizing antibodies, 
expressed in prokaryotic and eukaryotic 
cells.  
Detection of neutralizing antibodies in 
sera. 
 
Vaccination with recombinant G protein did not elicit 
good protection, despite the induction of neutralizing 
antibodies, and low levels of protection were only 
achieved when administrated by intraperitoneal 
injection in combination with an adjuvant.  
Due to its cost of production and route of delivery, 
does not appear to be suitable for mass delivery to 
fish fry. 
Synthetic 
peptide 
vaccines 
Peptide vaccines use short amino acid 
sequences as antigens. Are based on 
known antigenic epitopes of the VHSV G 
protein.  
Attenuated Aeromonas salmonicida was 
tested as a vector for the expression of 
VHSV G protein fragments. Fish immunized 
by bath immersion or spray was 
moderately protected against homologous 
challenge.  
Synthetic peptide vaccine alternatives were also 
poorly immunogenic. 
DNA vaccines 
DNA vaccination relies on the use of a 
gene or genes encoding protective 
antigens, instead of the antigens 
themselves. These vaccines are based on 
G gene of VHSV. 
They have been shown to be highly 
efficacious in inducing specific and 
protective immunity under a wide range of 
conditions and in several fish species. 
DNA vaccines also protect against 
heterologous strains but with reduced 
efficacy compared to the homologous. 
Their efficacy varies with the relatedness of the 
challenge strain to the strain used to create the 
vaccine. 
Several aspects concerning technical (route of 
delivery) and safety problems (fish DNA persistence) 
need to be addressed. 
Introduction 10 
B. VIRAL HAEMORRHAGIC SEPTICAEMIA VIRUS (VHSV) 
1. Nomenclature and classification 
The International Committee on Taxonomy of Viruses (ICTV) [89] assigned the 
Novirhabdovirus as a new genus, which belongs to the family Rhabdoviridae [90] within the 
order Mononegavirales. Novirhabdovirus genus includes four members that are exclusively fish 
pathogens: Viral haemorrhagic septicaemia virus (VHSV), Infectious haematopoietic necrosis 
virus (IHNV), Hirame rhabdovirus (HIRRV) and Snakehead rhabdovirus (SHRV); and the prototype 
species of the novirhabdovirus is IHNV [91]. 
VHSV (initially named as Egtved virus) is the aetiological agent of the viral haemorrhagic 
septicaemia disease, and its name was recently changed to Piscine novirhabdovirus (formerly 
Oncorhynchus 2 novirhabdovirus), while IHNV has been renamed as Salmonid novirhabdovirus. 
These names were suggested by Kurath and Kuhn to the ICTV Rhabdoviridae Study Group [92, 
93] in a move to highlight the exceptionally wide host range of VHSV, compared to the more 
narrow host range of other genus members such as IHNV, which is limited to salmonid fish. 
However, despite the new names approved, these viruses are still known as VHSV and IHNV and 
this nomenclature is used for convenience in this thesis. 
In contrast to other mammal and fish rhabdoviruses (e. g.: Vesiculovirus, SVCV), members 
of the genus Novirhabdovirus are distinguished by the presence of a unique additional gene, 
called the ‘non-virion’ or ‘NV’ gene, which gives the name to the genus (Figures 2 and 3), and 
has no significant similarity with any other viral gene [46]. In addition, comparison of nucleotide 
and amino acid sequences of the structural proteins also supported the classification of the 
novirhabdoviruses into a separate genus (Figure 2) [94]. 
2. The genome organisation, replication and virion properties  
The typical novirhabdoviral genome contains six open reading frames (ORF) and encodes 
five basic structural proteins (namely in the 3′ to 5′order): nucleoprotein (N), polymerase-
associated phosphoprotein (P), matrix protein (M), glycoprotein (G), and large RNA-dependent 
RNA polymerase (L); and a non-structural protein (‘non-virion’ or NV), located between G and L 
proteins (Figure 4A) [95-97]. Additionally, all the ORF of VHSV are separated by untranslated 
sequences, known as gene junctions, whereas the untranslated regions at the 3'- and 5'-end are 
known as the 'leader' and 'trailer', respectively [89, 96]. The gene order of VHSV is 3'-leader-N-
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P-M-G-NV-L-trailer-5' as other members of the Novirhabdovirus genus (Figures 3 and 4A) and 
the genes are sequentially transcribed [96].  
 
Figure 2. Phylogenetic tree of viruses in the Rhabdoviridae based on alignment of nucleoprotein gene 
sequences. The tree was generated by the neighbor-joining method using 1000 bootstrap replicates 
(obtained from [98]). 
 
All the genes of VHSV start with a conserved gene-start sequence (-CGUG-), followed by an 
ORF and a conserved gene-end sequence (A/GUCUAU/ACU7) with 7 uracil (U) residues, which 
are polyadenylation signal for polymerase when it transcribes a gene. After this poly (A) signal, 
there are two conserved intergenic di-nucleotides (G or A), which are untranscribed and act as 
spacers between the two genes [99]. The viral polymerase transcribes the genome responding 
to these specific gene-start and gene-end sequences and skips these two nucleotides to start 
transcribing the next gene and to yield a series of discrete monocistronic mRNAs [100]. The 
mRNAs are not produced in equimolar amounts; rather, their relative abundance decreases with 
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distance from a single 3′-proximal polymerase entry site (such that N > P > M > G > NV > L) [101-
104], being promoter-proximal genes transcribed in greater abundance than distal genes [105].  
 
 
Figure 3. Comparison of the genome structure among two fish rhabdovirus: (A) a member of the genus 
Novirhabdovirus, viral haemorrhagic septicemia virus (VHSV); and (B) a typical member of the genus 
Vesiculovirus, spring viremia of carp virus (SVCV). Predicted SVCV MW are based on [106] and for VHSV 
on [96]. 
 
Virions are bullet-shaped (approximately 70 nm in width and 180 nm in length) (Figure 4B) 
and contain a simple negative-sense, single-stranded RNA (ssRNA) genome of approximately 11-
11.2 kb and possess an envelope that consists of a lipid bilayer membrane (Figure 4C) [96]. 
3. The structural proteins: characteristics and functions 
As reviewed above, VHSV virions have five structural proteins designated N, P, M, G and L. 
The G and N genes of VHSV are less genetically variable than the NV gene [24], whereas the P 
gene and the M gene appear to be even more highly conserved [107]. The N gene’s more rapid 
evolutionary rate may enhance ability of the virus to evade the host’s induction of interferon 
and chemokines, as hypothesized for rabies [108]. 
In general, the primary functions and basic characteristics of the five structural proteins of 
novirhabdoviruses have been assumed to be the same as demonstrated for the homologous 
proteins of mammalian rhabdoviruses vesicular stomatitis (VSV) and rabies viruses (RV), and are 
conserved across all rhabdoviruses. However, some functions and characteristics may differ 
among them or has not been specifically proven in most cases (see Table 2 for summary of their 
characteristics and functions). 
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Figure 4. Organization of the VHSV genome (A), morphology (B) and schematic representation of 
structural components of rhabdoviruses (C). (A) The gene order of VHSV is 3'-leader-N-P-M-G-NV-L-trailer-
5'. The arrow indicates the sense of gene transcription from the 3’ to 5’ end of the template virus RNA 
and in decreasing molar abundances [95]. Genome organization and predicted molecular weights (MW) 
in kilodaltons of a typical member of the genus Novirhabdovirus, Viral haemorrhagic septicaemia virus 
(VHSV). Predicted VHSV molecular weights are based on [109]. (B) Electron micrograph depicts the bullet-
shaped morphology of virions from the Rhabdoviridae family (image obtained from CDC, 1981). 
 
The structural proteins consist of two major functional units: a ribonucleoprotein (RNP) 
complex unit composed of N, P, and L for transcription and replication of genomic and anti-
genomic viral RNA, and envelope components composed of G and M proteins to allow RNP in 
and out of the host cell [96]. 
 
Ribonucleoprotein (RNP) complex 
The nucleoprotein (N) of VHSV spans 404 amino acids and has a molecular mass of 44 kDa 
approximately. This is the earliest expressed and most abundant protein produced by the virus 
during VHSV infection. As a constituent of the RNP unit, the N-protein encapsidates the genome 
(negative-strand RNA, vRNA) protecting it from nucleases and forms part of the 
ribonucleoprotein core structure of virion, which serves as the template for viral transcription 
(viral RNA to mRNA), for replication (cRNA to viral RNA) and viral genome copying (Figure 5). 
This encapsidated genomic RNA is also associated with the phosphoprotein (P) and polymerase 
protein (L), which are involved in viral protein synthesis and replication [110].  
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Table 2. Summary of the characteristics, functions, and molecular weights (MW) of the five structural 
proteins of VHSV based on [96]. 
VHSV Structural Proteins MW Characteristics and functions 
 G Glycoprotein 
57-63 
kDa 
Surface antigen (which forms trimers) that facilitates 
virus attachment and entry into the host cell and elicits 
the production of neutralizing antibodies. It has been 
used for vaccination experiments and also for VHSV 
genotyping/typing. 
 M Matrix protein 
20 
kDa 
Apart from its critical role in viral assembly and 
budding, it is also implicated in host gene suppression 
during infection. 
 N Nucleoprotein 
44 
kDa 
N is bound to the viral RNA (protecting it from 
nucleases) and modulates the balance between genome 
transcription and replication processes. 
 P Phosphoprotein 
25 
kDa 
P serves as a cofactor for the viral polymerase allowing 
viral replication and inhibits activation of interferon 
response in the host cells (i.e., blocks antiviral responses). 
 L Polymerase 
224 
kDa 
Guides viral replication and transcription and it also 
plays a role in host specificity and temperature. 
 
The phosphoprotein (P) spans 231 amino acids and has a molecular mass of 25 kDa. Its role 
is to facilitate viral replication and inhibit the activation of interferon response in the host cells. 
The interaction of N protein with phosphoprotein (P) abolishes any non-specific RNA binding, 
and prevents phosphorylation. The phosphoprotein has a highly variable N-terminal half and a 
conserved C-terminal half [99]. Phosphoprotein, which is a non-catalytic polymerase-associated 
protein, has a putative conserved domain for binding with L protein to be a complete RNA-
dependent-RNA polymerase (RdRp) complex [111, 112]. Based on vesicular stomatitis virus 
(VSV, Rhabdoviridae), the P has three domains: an N-terminal domain to bind with the L protein, 
a central oligomerization domain, and a C-terminal domain to bind with the N-RNA template 
[113, 114]. 
The polymerase gene encodes a protein (L protein) of 1,986 amino acids with a predicted 
molecular weight of approximately 224 kDa. The RNA polymerase activity of the large protein 
(L) guides viral transcription and replication [107], and potentially plays a role in growth of the 
virus at different temperatures [107]. 
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Figure 5. Transcription and replication cycle of negative-strand RNA viruses. In the absence of free 
nucleocapsid (N) protein, the RNA-dependent-RNA polymerase (RdRp) complex transcribes the genome 
to make mRNA at the early infection stage. After translation of the N proteins, the complex uses the highly 
N-coated complementary RNA (cRNA) genome as a copy to make more viral RNA (vRNA) and to produce 
more viral proteins, especially RNPs [115] (Figure modified from [116]). 
 
Envelope components 
The viral envelope contains the major surface antigen, the glycoprotein (G). The G protein is 
inserted as trimers into the viral membrane and it is the only one expressed at the virion surface 
[117, 118]. The G protein encases the virus and triggers the attachment and entry of the virus 
into the host target cells by binding to a cellular receptor (receptor-mediated endocytosis), 
which has been identified as fibronectin for VHSV [118, 119]. The G-mediated fusion process 
depends on the pH, thus VHSV G protein at pH 6.5 is exposed at the cell surface in an inactive 
fusion state, and at pH > 7 at the cell surface is needed to shift towards an activated state [120]. 
The G protein is also the major antigenic protein of novirhabdoviruses, eliciting strong innate 
and adaptive host immune responses [85, 121] and being the only protein responsible for the 
synthesis of neutralizing antibodies, which constitute the main humoral component of the fish 
long-term protective response against rhabdoviruses. Studies with subunit and DNA vaccines 
have clearly indicated that the G protein alone is necessary and sufficient to stimulate protective 
immunity for VHSV, IHNV and HIRRV [85, 122-126]. However, vaccination with the recombinant 
G protein did not protect as well as when using the intact virus, probably because of 
inappropriate folding as suggested by Boudinot et al. 2004 [127]. Moreover, targeted mutations 
on G allow attenuation of virulence [128-130]. 
The matrix (M) protein, is localized between the inner leaflet of the surrounding lipid bilayer 
membrane and the nucleocapsid. M protein normally functions in viral assembly by binding the 
ribonucleoprotein core of the virus to the host plasma membrane during the budding process 
Ribonucleoprotein (RNP) 
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Genomic RNA           
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[131]. The M protein interacts with the G protein to assist in viral budding [73]. Apart from its 
critical role in viral assembly and budding, the M-protein has been also implicated in anti-host 
functions (or cytopathic functions) that are genetically separable from viral assembly functions 
(and vice versa) [132] and are still essential for efficient viral replication. Thus, in Vesicular 
Stomatitis virus (VSV), the prototype rhabdovirus, the M protein appears to block host gene 
expression [132-134] and/or inhibits export of mRNA from the nucleus [135], effectively 
blocking translation of host proteins—including those thought to be involved with the viral 
response pathway [136]. Moreover, VSV M protein induces apoptosis, which probably correlates 
with the ability to inhibit host gene expression [137]. According to Chiou et al. 2000 [138], the 
IHNV M protein induced the inhibition of host-directed gene expression and stimulated 
apoptosis when transfected into a fish cell line. This indicates a role for the IHNV M protein in 
immune evasion strategies similar to that of the VSV M protein. Meanwhile, several M variants 
have been found for VHSV [107] but little else was known about VHSV anti-host processes until 
Pore 2012 [139] and Ke et al. 2017 [140] reported that VHSV M protein acts similarly to other 
rhabdoviral M proteins (such as VSV, rabies and IHNV) in shutting down general host 
transcription, the inhibition of interferon promoter and assist in viral budding [73, 139]. In 
addition, these authors also established that VHSV M protein expressed after transfection 
located to nucleus and cytoplasm. 
4. Life cycle of VHSV 
Understanding the viral infection cycle is important to define where the host immune 
system encounters virus-associated molecules. The general rhabdovirus life cycle, derived from 
VSV, has been reviewed extensively elsewhere and involves the five structural proteins found in 
all rhabdoviruses [141]. Briefly, the rhabdovirus enters its target cell by receptor-mediated 
endocytosis, which is triggered following engagement of a cell surface receptor by the viral G 
protein. The viral and endosomal membranes subsequently fuse and the viral nucleocapsid is 
released into the cytoplasm of the host cell. Within the cytoplasm, the viral genes are 
sequentially transcribed from the genome using an RNA-directed RNA polymerase that 
accompanies the infecting virion, viral proteins are synthesized by host cell machinery, and new 
copies of the genome are synthesized from a full-length, single-stranded RNA anti-genome. To 
package the new virions, the N, L and P proteins, synthesized by free ribosomes in the cell 
cytoplasm, bind to the newly synthesized copies of the viral RNA genome to form the 
ribonucleoprotein (RNP) core, which associates with the M protein to produce the RNP-M 
complex. The G protein is synthesized by endoplasmic reticulum (ER)-bound ribosomes. It is 
glycosylated and further modified within the ER and Golgi apparatus prior to transport and 
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insertion into the plasma membranes on the host cell surface. The RNP-M complex migrates to 
regions of the plasma membrane enriched with viral G proteins. The G protein-studded host cell 
plasma membrane is subsequently captured by RNP-M protein complex as it buds from the cell 
to create fully enveloped rhabdovirus (Figure 6). 
 
Figure 6. The lyfe cycle of VHSV consist of: (1) attachment and receptor-mediated endocytosis, (2) 
uncoating, (3) transcription of viral genome, (4) translation of viral proteins, (5) replication of viral 
genome, (6) virion assembly and, finally, (7) budding. (1) The glycoprotein (G) binds to a cell surface 
receptor (fibronectin) allowing viral endocytosis into the host cell. (2) Endosomal acidification triggers 
a conformational change of the G that fuses the viral envelope with the endosomal membrane and 
releases the viral ribonucleoprotein (RNP) complex (consisting of the N, P, and L proteins and the 
negative-sense vRNA) into the host/cell cytoplasm. (3) Within the cytoplasm, the nucleoprotein (N) 
dissociates from the vRNA (-) and the phosphoprotein (P) activates the viral polymerase (L) to initiates 
the synthesis of positive-sense transcripts of all six viral genes (mRNA). (4) Viral proteins are 
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synthesized by host cell machinery (ribosomes) from mRNAs. The G protein is synthesized by 
endoplasmic reticulum (ER)-bound ribosomes, glycosylated and further modified within the ER and 
Golgi apparatus and finally transported and inserted into the host cell membrane. (5) When sufficient 
N has been translated to allow nascent vRNA (-) encapsidation, L synthesizes a full-length positive, 
complementary copy called the “antigenome”, cRNA (+). The antigenome is used as a template to 
direct synthesis of encapsidated minusstrand genome and for the synthesis of both new mRNAs 
(secondary transcription) and antigenomic RNA. (6) To package the new virions, the N, L and P 
proteins, synthesized by free ribosomes in the cell cytoplasm, bind to the newly synthesized copies 
of the vRNA (-) to form the ribonucleoprotein (RNP) core/complex, which associates with the matrix 
protein (M) to produce the RNP-M complex. The RNP-M complex migrates to regions of the plasma 
membrane enriched with viral G proteins and the M binds the cytosolic domain of G, linking the viral 
genome and its associated proteins responsible for encapsulating the virion with the host membrane. 
(7) Fully formed and host-membrane encapsulated virions are released to infect new cells. 
 
5. Genotypes and serotypes 
There are three recognized serotypes of VHSV defined by means of different versions of the 
neutralization test: Type 1, represented by Strain F1; Type 2, represented by the Hededam 
isolate, both isolated from Danish rainbow trout [142, 143], and Type 3, represented by the 
French strain 23/75 isolated from brown trout Salmo trutta far10 by De Kinkelin and Le Berre 
1977 [144]. However, in spite of the existence of serological differences between isolates, 
serological cross-reactivity occurs among the three serotypes and does not allow discrimination 
between marine and freshwater isolates [145]. Because VHSV isolates from wild marine fish are 
serologically indistinguishable from the continental isolates [26, 146-148], development of 
molecular methods based on the analysis of sequences of viral genes provide the most 
discriminatory way of typing VHSV. 
Phylogenetic studies based on sequencing of full-length or truncated genes from the N gene 
[149-151], G gene [47, 149] and NV gene [149] of VHSV isolates worldwide showed that VHSV 
can be classified into four major genotypes (designated from I to IV) [47, 150, 152, 153]. 
Additionally, genotypes I and IV are further divided into five (Ia-Ie) [47] and three (IVa-IVc) [24] 
sublineages, respectively, based on their reactivity to different monoclonal antibodies [154]. 
These genotypes are correlated to the geographical regions or areas of isolation rather than host 
specificity or pathogenicity, with isolates from genotypes I, II and III circulating in Europe and 
genotype IV consisting of isolates from North America and East Asia [47, 146], as detailed in 
Table 3. 
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Table 3. Currently known genotypes and distribution of the viral haemorrhagic septicaemia virus (VHSV).  
Genotypes Location Subtypes Location References 
I 
Europe  
and  
Japan (Ib) 
Ia Continental Europe A 
Ib 
Baltic and North Sea  
and Japan 
B 
Ic 
Denmark and Germany  
(some mainland lakes) 
C 
Id 
Water along Norway and 
Finland, Baltic Sea. 
D 
Ie Black Sea (Georgia and Turkey) E 
II --- 
Baltic Sea and rivers flowing 
into it 
F 
III --- 
North Sea and NE Atlantic 
Ocean (restricted to waters 
connected to the North Atlantic 
Ocean) 
G 
IV 
North America 
and  
East Asia 
IVa 
West coast of North America 
(Pacific Ocean) and East Asia 
(Korea and Japan) 
H 
IVb Great Lakes of North America I 
IVc 
East Coast of North America 
(Atlantic Ocean) 
J 
 
A: [47, 152, 155]; B: [47, 51, 152]; C: [156]; D: [157]; E: [158]; F: [51, 158, 159]; G: [47, 51, 55, 56, 58, 150, 152, 160, 
161]; H: Pacific Ocean [26, 50, 148, 162] , and East Asia [163, 164]; I: [56, 165]; J: [24]. 
 
Within genotype I, sublineage Ia includes freshwater isolates from continental European 
countries, and is further divided into two distinct sublineages: Ia1, comprising strains isolated 
mainly from Danish rainbow trout; and Ia2, representing viruses that predominantly originate in 
continental Europe. Sublineage Ib circulates in marine fish of the Baltic and North Sea and the 
English Channel. Sublineage Ic is a smaller group consisting of Danish rainbow trout isolates from 
the 1980s. VHS outbreaks in Finnish sea reared rainbow trout in the Baltic Sea grouped together 
in genotype Id [166], together with some old Scandinavian isolates from the 1960s. Sublineage 
Ie is formed by isolates from Georgia and Turkey. In addition, genotypes II and III appear to be 
restricted to the Baltic Sea and the North Atlantic Ocean. Finally, genotype IV has been isolated 
from marine and freshwater fish in North America (subtypes IVa, IVb and IVc) [56] and northeast 
Asia, including Japan and Korea (only subtype IVa) [167]. Genotypes Ib and IVa have also been 
reported in marine waters of Japan [24, 47].  
The host range and the pathogenicity appear, at least to some extent, to be linked to the 
genotype. In general, isolates of VHSV from rainbow trout are principally members of genotypes 
Ia, Ic and Id, and the isolates adapted to marine host species are members of genotypes Ib, Ie 
and II–IV. Moreover, VHSV marine isolates tested so far typically produce little or no mortality 
Introduction 20 
in rainbow trout fry following waterborne challenge [145, 168]. This is consistent with the well 
supported hypothesis that VHS disease in trout farms is due to VHSV host jumps from marine 
reservoir fish into cultured rainbow trout, followed by adaptation to higher virulence in trout 
[47]. Interestingly, molecular analysis provides evidence that the marine environment is the 
original reservoir of VHSV and that species barrier jumps may have occurred several times, 
mainly from marine fish to trout [169]. Finally, it is still not clear whether VHSV isolates represent 
three serotypes or subtypes within a single serotype [170]. Thus, VHSV isolates share several 
antigenic epitopes, although serogrouping does not correlate with genotypes. 
In recent years, genotype characteristics have been used to evaluate viral properties and 
molecular epidemiology of VHSV from both freshwater and marine fishes. Although genotyping 
is useful, a quick and simple detection method that can discriminate the different genotypes is 
desirable for a more efficient prevention of the spread of genotypes to new geographical areas. 
Some authors [171] demonstrated the possibility of producing MAbs (monoclonal antibodies) 
that recognize a specific genotype or subtype of VHSV; i.e.: MAb VHS-10, which reacted only 
with genotype IVa in indirect immunofluorescence (IFI) and ELISA. Using cell cultures that were 
transfected with each of the viral protein genes, it was shown that the MAb VHS-10 recognizes 
a nonlinear genotype IVa-specific epitope on the VHSV N protein. 
 
6. Immunity to fish rhabdoviruses: innate and adaptive responses 
 
The protective immune mechanisms against viruses in fish are mounted in similar fashion 
than those observed in mammals [172]. Teleost fish are known to possess the major TLR families 
plus an expanded set of unique non-mammalian TLR genes and gene variants [173, 174], as well 
as pattern recognition receptors (PRRs) that include the cytoplasmic viral detection receptors 
retinoic acid inducible gene I (RIG-I) and melanoma differentiation-associated gene-5 (MDA5), 
laboratory of genetics and physiology 2 (LGP2) and the associated signaling molecule 
mitochondrial antiviral signaling (MAVS) protein [74, 175, 176], which are commonly referred to 
together as “RIG-I-like helicases (RLHs)” [177]. RLHs contain helicase domains that are capable 
of “sensing” viral pathogen-associated molecular patterns (PAMPs), particularly dsRNA and 
uncapped ssRNA. The interaction causes a conformational change in the RLH exposing a Caspase 
Activation and Recruitment Domain (CARD) allowing it to signal to the downstream adaptor 
protein, mitochondrial antiviral signaling (MAVS) protein (also known as VISA/IPS-1/Cardiff) 
[178]. 
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The cascade activates transcription factors including Interferon-Regulatory Factors (IRFs), 
resulting in transcriptional activation of responsive genes, type I IFNs in particular [179, 180]. 
This “first phase” of the innate immune response occurs primarily in infected cells, and many of 
the above signaling components have been identified in, and/or cloned, in fish as well as 
humans, mice and other organisms. Overexpression of the mentioned proteins in cultured cells 
results in a decreased viral titer following infection, suggesting that the antiviral roles they play 
in mammals originated in earlier vertebrates, such as fishes [74, 181]. Characterization of the 
innate immune response in fish rhabdoviruses has been accelerated due to the genomic 
information available for model and commercially important fish species. Genes encoding 
critical cytokines, chemokines, and other innate effectors have been identified in fish including 
those encoding both type I IFNs (also called IFNφ) and type II IFNs (also called IFNγ) [182, 183]. 
Fish type I IFNs (IFNφ) are split into two major groups, which differ in the number of conserved 
cysteine (C) residues (group I—2C and group II—4C) [184] and appear to bind different receptors 
[185, 186]. In general, group I IFNs are expressed in a wide range of tissue types while group II 
IFNs are more abundant in hematopoietic-derived tissues and cells. Multiple gene copies of IFNγ 
exist in fish species but these genes are not duplicated to the same extent as the type I IFNs 
[184].  
Once type I IFNs are transcribed and translated, their protein products are processed and 
secreted from the cell into the surrounding tissues and to circulation. IFNs bind to high affinity 
cell surface receptors on neighbouring or distal cells and activate JAK1 and TYK2 tyrosine kinases 
leading to the phosphorylation of STAT1 and STAT2. STAT1 and STAT2 dimerize and then 
complex with IRF9 to form the multimeric transcription factor complex IFN stimulated gene 
factor 3 (ISGF3). After translocation to the nucleus, ISGF3 transcriptionally upregulates hundreds 
of IFN-stimulated genes (ISGs) [187]. The protein products of these genes work in concert to 
induce physiological changes that lead to an antiviral state for the cell [188]. 
The IFNs signal through the conserved JAK/STAT pathway and up-regulate the expression of 
>300 IFN stimulated genes (ISGs) [189, 190], which establish the ‘anti-viral’ state [191]. Many of 
these ISGs have direct anti-viral function (i.e.: Mx [192]) while the functions of other ISGs remain 
unknown. Replication of fish rhabdoviruses is inhibited by pre-activation of the IFN system 
regardless of the method used, including using IFN-containing supernatants, poly I:C [193], 
rhabdoviral G protein transfection [194-196] or recombinant IFN [197, 198]. Early studies clearly 
indicate functional IFN in sera derived from fish infected with VHSV [199], IHNV [200] or SVCV 
[201]. Later studies confirmed these results and demonstrate transcriptional up-regulation of 
both group I and II IFN genes after infection with these same viruses [202-204]. IFNγ genes are 
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also regulated early in rhabdoviral infection [203]. Rhabdoviral infections are controlled by fish 
group I and II IFNs [197, 202, 204-206]. Host-virus dynamics at virus entry points (i.e., the fins 
[40]) may help limit the internal spread of viral infection by alerting systemic sites via IFNs and 
other cytokines. 
Other important aspect in long-term immunity against rhabdoviruses is the humoral 
immune response. Neutralizing antibodies induced by infection and/or vaccination are critical 
components of long-term adaptive immunity to fish rhabdoviruses [207]. Passive immunization 
with sera containing neutralizing antibodies protects recipient juvenile trout from IHN and 
Pacific herring from VHS, even when titers fall below detectable levels [208, 209]. Most studies 
of fish rhabdoviruses have focused on the highly protective neutralizing antibody response but 
it is possible that non-neutralizing or other types of antibodies may also play a role. In vitro 
rhabdoviral neutralization is complement-dependent but the exact mechanism by which 
complement aids viral neutralization is still unclear [210, 211]. Neutralizing antibodies are 
unlikely to play a role in surviving the acute infection phase in coldwater fish species since 
neutralizing antibodies typically are not detectable until several weeks post-infection.  
The study of attenuated or low virulence virus types indicates that a certain threshold of 
virus replication must occur for fish to develop a broadly protective antibody response, even if 
a robust innate response is induced [212]. Lorenzen and LaPatra published a comprehensive 
review of the antibody response to fish rhabdoviruses in 1999 [211], and since then, this area 
has not received much new attention. Studies of the G protein DNA vaccines over the past 
decade have reaffirmed the central role of neutralizing antibodies in protective immunity [85, 
213-217]. However, genomic approaches combined with functional studies have brought 
exciting new insights into B cell biology in teleost fish. Fish B cells show phagocytic behaviour 
suggesting that fish B cells may also function as part of the innate immune system [218]. 
Furthermore, it is now known that teleost fish possess three or more immunoglobulin isotypes 
including IgM, IgD and IgT (IgT is also called IgZ in zebrafish) [219]. A recent study indicates that 
B cells expressing IgM respond to antigenic stimulation in systemic tissues while B cells 
expressing IgT are key to the mucosal immune response [220]. To date, tools such as monoclonal 
antibodies to fish IgM and IgT now exist [220, 221], which will allow the characterization of 
mucosal immunity and its relationship to systemic protection against rhabdoviruses. Finally, 
there has been much progress in unraveling the complexity of the fish complement system 
[222], which may help to finally define which complement components contribute to virus 
neutralization.  
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The cellular immune response to fish rhabdoviruses also has a key role in protection. 
Although DNA vaccination with the novirhabdoviral G protein triggers production of protective 
neutralizing (and perhaps other) antibodies, high levels of specific protection after DNA 
vaccination are also observed without detectable neutralizing antibodies [78, 223] indicating a 
potential role for specific cellular immunity. Major advances have been made recently in our 
understanding of fish T cells [224]. Teleost fish possess a wide range of T cell associated genes, 
including genes that encode T cell receptor chains and various other T cell associated co-
receptors, co-stimulatory molecules and cytokines [224]. Many of these genes show up-
regulated expression following rhabdoviral infection and/or G protein DNA vaccination [225]. 
There is a limited understanding of the role T cells play during fish rhabdoviral infection with 
most work focusing on cell-mediated cytotoxicity (CMC). However, VHSV infection and DNA 
vaccination with the VHSV G protein induces clonal expansion of T cells, as shown by spectratype 
analysis of the complementarity-determining region 3 (CDR3) of the TCR-β chain [226, 227], 
supporting a role of teleost T cells in controlling this virus. Interestingly, the dominant CDR3 
profiles are the same for both VHSV infection and G protein DNA vaccination suggesting that 
important T cell epitopes are localized within the G protein. Future studies examining the role 
of T cells during rhabdoviral infection will benefit from new reagents that can discriminate 
among T cell subsets [224], including monoclonal antibodies against the CTL surface marker CD8.  
Studies of mammals and other vertebrate species indicate that NK cell activity is mediated 
by many different receptor types that can be specific to an individual animal species or even to 
a cell lineage [228]. Candidate NK receptor families in fish include the novel immune type 
receptors (NITRs), novel Ig-like transcripts (NILTs), leukocyte immune type receptors (LITRs), and 
possibly others [228]. Genomic characterization of fish species has enabled the identification of 
these polymorphic and polygenic receptor families, but there has been limited validation that 
these receptors have a functional role in NK activity. Functional studies of specific CMC were 
made possible in fish following the development of isogenic fish and major histocompatibility 
complex (MHC) I matched cell lines for both crucian carp and rainbow trout [229-231]. In a 
previous study, peripheral blood lymphocytes from rainbow trout infected with VHSV exhibit 
significant CMC to MHC class I matched target cells infected with VHSV but not to VHSV infected 
xenogeneic targets [231]. However, rainbow trout survivors re-exposed to VHSV mounted a 
kinetically faster, VHSV-specific CMC response, as well as a nonspecific CMC response against 
VHSV infected xenogeneic targets (starting at 11 days post-infection). The delayed nonspecific 
CMC response in trout contradicts the mammalian paradigm where primary CMC is nonspecific 
and results from NK cell activity while later CMC is pathogen-specific due to clonal expansion 
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and action of virus specific CTLs [232]. Taken together, these studies suggest a role for cellular 
immunity—particularly CMC—in the host response to fish rhabdoviruses. However, more basic 
research is needed to definitely identify the cells that contribute to key cellular effector 
functions in fish. 
 
C. THE NV GENE OF NOVIRHABDOVIRUS 
 
1. NV gene and protein  
The non-virion (NV) gene is approximately 500 nucleotides in length and codes for a small 
protein  of 111 amino acids (13.2 kDa) for IHNV, 122 amino acids (13.6 kDa) for VHSV, 120 amino 
acids (13.7 kDa) for HIRRV, and 122 amino acids (13.6 kDa) for SHRV [95, 97, 233]. The NV protein 
is not present in the virion particles, as its name suggests [46, 96, 97, 234]. Despite of the 
presence of the NV gene in the four novirhabdovirus species mentioned above as a common 
characteristic, NV proteins showed relatively high homology intraspecies but widely divergent 
interspecies sequences [149, 233].  
 
 
Figure 7. Phylogenetic tree depicting the homology and clustering 
among four NV amino acid sequences of novirhabdovirus: VHSV NV 
(07.71 strain, GenBank AJ233396), HIRRV NV (GenBank U47847.1), 
IHNV NV (Oregon69 strain, Uni-ProtKB Q08455), and SHRV NV 
(GenBank NC_000903.1). 
 
NV gene was firstly described from IHNV by Kurath et al. 1995 [95] and further completely 
sequenced in the same year  [235, 236], being one year later identified for VHSV NV gene [97]. 
Regarding homology among NV proteins, initial studies pointed out less than 20% amino acid 
identity according to Morzunov et al. 1995 [236], and more complete identity studies defined 
values between 15% and 50% for VHSV vs IHNV (16.3 %), IHNV vs HIRRV (51.3 %), VHSV vs HIRRV 
(15.7 %) and VHSV vs SHRV (23,2 %) [233] (Figure 7). In spite of this, NV from different 
novirhabdovirus (except for SHRV) seems to be implicated in pathogenesis [237, 238] leading to 
similar effects as discussed below. In Europe and USA, VHSV and IHNV have caused important 
outbreaks in the last decades, which have allowed their study and the characterization of 
multiple NV sequences.  To date, there are more than 60 and 120 amino acid accession entries 
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for IHNV NV (https://www.ncbi.nlm.nih.gov/protein/?term=NV+IHNV) and VHSV NV 
(https://www.ncbi.nlm.nih.gov/protein/?term=NV+VHSV), respectively. 
2. NV role: replication, pathogenicity and immune response 
The presence of a functional NV gene with the same location and similar size in all 
novirhabdovirus, which have relatively small genomes where over 90% of the nucleotides are 
protein-coding, suggested that the conserved NV gene in this genus could play a critical function 
for novirhabdovirus [239]. However, several observations were contradictory for a biological 
role of NV, such as the absence of amino acid sequence homology among NV proteins from 
different novirhabdovirus and the lack of a gene encoding NV in some fish rhabdovirus like the 
spring viremia of carp virus (SVCV). For these reasons, several investigations have been done to 
uncover the role of this protein. 
One of the first evidences of localization and expression of NV from both IHNV and VHSV 
was carried out by Schutze et al. 1996 [97], since they could detect specifically those NV proteins 
in infected RTG-2 and EPC cells with VHSV and IHNV, respectively. In that report, the authors 
observed a nuclear and cytoplasmic expression pattern for IHNV NV, and limited to cytoplasm 
for VHSV NV in the absence of cross-reaction. Studies carried out many years later confirmed 
those expression patterns and established their correlation with function for IHNV [238]. 
A first approach to demonstrate a biological role of NV was carried out by Chiou et al. 2000 
[138], in whose work fish cells transiently transfected with a plasmid expressing the IHNV NV 
gene were found to undergo cell rounding. That suggested a possible interaction between NV 
protein and the cytoskeleton, and explained the differences found in the cytopathic effect (CPE) 
induced by recombinant IHNV (rIHNV) viruses expressing NVIHNV or NVVHSV, being the aspect of 
the rounding cells more pronounced in the presence of the NV of VHSV [240]. 
However, it has not been possible to delve into the NV function until a reverse genetics 
system was established for the recovery of a non-segmented negative-stranded RNA virus: the 
rabies virus [241]. Since then, this reverse genetics system has been adapted to numerous fish 
RNA viruses [242] such as the novirhabdovirus SHRV [239], IHNV and VHSV [75, 243-245]. The 
ability to recover live virus from a DNA copy of the RNA genome (called "reverse genetics"), 
opens up the possibility of deleting genes to study their function among other applications. 
The NV role has been then examined using deletion mutants of different novirhabdovirus 
generated by this technology mentioned above [242], but their results differed substantially 
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among viruses (e. g.: SHRV vs VHSV). While NV was not essential for in vitro or in vivo SHRV 
production on warm-water flatfish [239, 246], the recovery of IHNV and VHSV NV-deletion 
mutants demonstrated that NV protein was dispensable but necessary for an efficient virus 
replication in cell culture [237, 240, 244, 245, 247] and essential for virus pathogenicity in 
rainbow trout [40, 240], yellow perch [237] and Japanese olive flounder [247] (Table 4). Thus, 
recombinant IHNV and VHSV lacking whole NV gene showed severely retarded growth (one to 
two logs lower in cell culture than the wild-type counterparts) compared to WT and exhibited 
highly attenuated phenotypes in fish, which were also shown to have a limited persistence in 
internal organs of the fish [42, 247] or even to be blocked in the fins without any further spread 
into the infected fish [40]. However, the role of HIRRV NV in replication and pathogenicity has 
not been studied yet.  
 
Table 4. Summary of all the studies in which NV gene was knocked-out and the recombinant viruses 
recovered by reverse genetics to study the role played by the NV protein on novirhabdovirus replication 
in vitro and on pathogenicity in vivo.  
REFERENCES Virus 
Recombinant 
Viruses 
NV ROLE 
in vitro in vivo Conclusion 
Johnson et al. 2000 [239]  
SHRV 
rSHRV-truncated 
NV ORF Replicated  
in EPC cells 
----- 
Not required 
for efficient 
viral 
replication and 
pathogenesis Alonso et al. 2004 [246] rSHRV- ΔNV 
Virulent in 
zebrafish 
Biacchesi et al. 2000 [244] 
IHNV 
rIHNV-ΔNV  
rIHNV-ΔNV-GFP 
rIHNV-ΔNV-CAT 
Replicated poorly 
in EPC cells  
 
----- 
Required for 
efficient viral 
replication and 
pathogenesis 
Thoulouze et al. 2004 
[240] 
rIHNV-ΔNV-GFP 
Highly attenuated  
in rainbow trout 
Choi et al. 2011 [238] 
rIHNV-NV-ΔEGDL 
rIHNV-ΔNV-GFP 
Replicated poorly 
in RTG-2 cells 
----- 
Wu et al. 2018 [248] rIHNV-NV-ΔEGDL 
Stable replication 
in CHSE-214 cells 
Attenuated 
in rainbow trout 
Biacchesi et al. 2010 [245] 
VHSV 
rVHSV-ΔNV 
Replicated poorly 
in EPC cells 
----- 
Ammayappan et al. 2011 
[243] 
rVHSV-ΔNV-EGFP 
Highly attenuated  
in yellow perch 
Kim et al. 2011 [247] 
Highly attenuated  
in olive flounder 
 
 
Although these ΔNV-viruses were highly attenuated, they were all able to efficiently express 
detectable amounts of foreign proteins instead of the NV in cell cultures [245] and to induce 
neutralizing antibodies when injected into fish, allowing their use as vaccine vectors ([42, 244, 
249-251] and Harmache and Brémont, unpublished data). In fact, these NV-knockout variants 
have then been used to immunize fish against IHNV and VHSV, and a high degree of protection 
has been obtained in Japanese flounder against VHSV [42] and rainbow trout against IHNV [240]. 
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However, even though the NV deletion constitutes an attractive approach for the generation of 
safe live vaccines by attenuating virus virulence irreversibly while retaining protective 
properties, this process could unfortunately reduce its immunogenicity due to the reduction of 
viral antigens, as observed for rIHNV-ΔNV in vitro [240]. 
Interestingly, the IHNV and VHSV NV proteins (and no SHRV NV) share a similar function 
despite of the low percentage of homology between them (23%) [149, 233, 240, 242], since a 
recombinant IHNV virus in which the IHNV NV gene was replaced by that of VHSV (rIHNV-NVVHSV), 
was shown to replicate efficiently in fish cells and to induce similar cumulative percentage of 
mortality in vivo in rainbow trout compared to the wild-type (WT) IHNV [240].  
However, the interference with replication in vitro and pathogenicity in vivo are not the only 
known and proven effects of NV proteins. Comparative studies between wt and NV knockouts 
of IHNV and VHSV suggest that NV proteins may downregulate the induction of interferon (IFN) 
and interferon-stimulated genes (ISGs) in vitro and in vivo [238, 251], which are considered the 
first line of host defense against viral infection. Teleost fish IFNs can induce the expressions of 
several ISGs with antiviral activity. Among ISGs, those coding Mx proteins play an important role 
due to their direct antiviral activity and they have been considered as markers of IFN I activity in 
some fish studies [252, 253]. Thus, Choi et al. 2011 [238] observed that NV knockout IHNV 
induced higher levels of expressions of both ifn1 and mx1 genes than wild-type during in vitro 
infection of rainbow trout gonad cells (RTG-2). Similarly, Kim and Kim 2012 [251] observed the 
up-regulation of interferons and mx transcript levels during in vitro infection of cyprinid cells 
(EPC) and in vivo infection of olive flounder with NV knockout VHSV. Furthermore, according to 
Choi et al. 2011 [238], the inhibition of virus-induced IFN response depends on the NV nuclear 
localization in the infected cell, being the 32EGDL35 motif within NV responsible for driving IHNV 
NV to the nucleus. Although VHSV NV was reported to restore the normal growth of NV 
knockout IHNV [240] probably via inhibition of host IFN system as IHNV does (as it has been 
hypothesized by Choi et al. 2011 [238]), the underlying mechanisms of IFN inhibition of VHSV 
NV may be different from those of IHNV NV.  
It is unclear whether other novirhabdoviruses (apart from IHNV and VHSV) use the NV to 
inhibit the IFN system, but in the case of SHRV, an NV-knockout virus showed the same 
pathogenicity as wild-type virus, suggesting that this virus may cope with the host antiviral 
response using proteins other than NV [246]. But, it should be noted that the pathogenicity of 
the SHRV-ΔNV was assayed on zebrafish and by intraperitoneal injection, which do not reflect 
the SHRV natural host (snakehead fish) and its presumed route of infection (waterborne) [246]. 
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Other recent evidences also propose that VHSV NV protein suppresses TNFα-mediated NF-
κB activation [254]. These authors showed that pre-treatment of EPC cells with TNFα 
prevented CPE caused by VHSV infection, but no protective effect was observed when cells 
were treated with TNFα after VHSV infection, suggesting that immediate early TNFα-mediated 
responses inhibit VHSV replication and thus VHSV should possess an ability to evade or inhibit 
early TNFα-mediated antiviral responses to promote a successful replication in host cells. Those 
results were different from the results reported by Roca et al. 2008 [255] in which TNFα 
treatment resulted in increased susceptibility of zebrafish to SVCV infection and increased viral 
replication in ZF4 cells. However, even though SVCV is a member of the family Rhabdoviridae, it 
belongs to Vesiculovirus genus whose genome does not possess the NV gene [106, 256]. 
Therefore, there might be differences between VHSV and SVCV in the exploitation of TNFα-
mediated signaling pathways. Furthermore, Kim and Kim [254] observed that the NV knockout 
VHSV (rVHSV-NV-EGFP) induced significantly higher NF-kB activity in EPC cells than the wild-
type. This would suggest that VHSV adopts a strategy to suppress early activation of NF-kB in 
host cells through NV protein.  
Recently, Ammayappan and Vakharia (2011) [237] established that the NV protein had an 
anti-apoptotic function at early stages of infection in vitro. In that work, the authors 
demonstrated that NV knockout and NV-deficient viruses cause greater apoptotic effects than 
wild-type virus (rVHSV), as shown by DNA laddering and downregulation of caspase 3, 8, and 9 
activities. Moreover, a recombinant VHSV expressing the IHNV NV protein (chimeric rVHSV-NV 
IHNV) exhibited similar properties (growth, caspase induction, DNA fragmentation and viral 
protein synthesis) to those of the wild-type rVHSV, suggesting that NV protein of 
novirhabdovirus is capable of suppressing apoptosis non-specifically in EPC cells. 
By performing transfection experiments using an expression vector that codes for the IHNV 
NV protein, it was also observed that the expression of NV in trans can completely restore the 
antiapoptotic activity of VHSV during infection (data not shown by Ammayappan and Vakharia 
2011 [237]. Similarly, Romero et al. 2008 [250] observed that EPC cells infected with wild-type 
IHNV produced lower levels of apoptosis than recombinant IHNV carrying the green 
fluorescence protein (GFP) gene rather than the NV gene [250]. Moreover, the early apoptosis 
observed by Ammayappan and Vakharia (2011) [237] was accompanied by decreased 
production of viral progeny. These findings suggest that the antiapoptotic function of the NV 
protein observed in vitro can also correlate with the attenuation of the virus observed in vivo by 
Amappayapan et al. 2010 [75] and that the NV protein plays an indirect role in the pathogenesis 
of novirhabdovirus by promoting the viral growth by delaying the cellular apoptosis program. 
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3. Molecular mechanism of NV proteins 
NV proteins (except SHRV NV) have previously been shown to be involved in viral 
pathogenicity [40, 237, 240, 244, 245, 247], but the mechanisms by which NV proteins interfere 
with the innate host responses and, therefore, promote viral replication remain still unclear. Our 
study published in 2015 [257] and that is part of the present Thesis, aimed to find out in 
transcriptome possible targets implied in the inhibition of immune response in trout. Biacchesi 
et al. 2017 [258] developed an approach based on reverse genetics and interactomics and 
identified several NV-associated cellular partners as potential targets. Among these cell 
partners, they showed that NV proteins specifically interact with a protein phosphatase, 
Mg2+/Mn2+-dependent, 1Bb (PPM1Bb, PPC2 family) and recruit it in the close vicinity of 
mitochondria, a subcellular compartment important for retinoic acid-inducible gene-I- (RIG-I)-
mediated interferon induction pathway. PPM1Bb protein have recently been shown to 
negatively regulate the host antiviral response via dephosphorylating Traf family member-
associated NF-κB activator (TANK)-binding kinase 1 (TBK1) [259, 260]. They showed how VHSV 
and IHNV NV proteins seem to interact with PPM1Bb in a different manner; VHSV NV recruits 
PPM1Bb around mitochondria to dephosphorylate TBK1, and further interferes with the retinoic 
acid inducible gene-I (RIG-I) response, whereas IHNV NV could bind to PPM1Bb around 
mitochondria and nucleus, acting on nuclear substrates different from TBK1 for inhibiting RIG-I 
response [258]. In spite of these findings, more knowledge is needed about other molecules 
implied downstream TBK1 as mediators in signaling pathways, helping to define possible 
relationships between them. 
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Novirhabdovirus are fish pathogens of great importance for aquaculture worldwide. 
Previous studies defined NV proteins (except SHRV NV) as responsible for in vivo pathogenicity 
of novirhabdovirus and also showed a clear relationship between their subcellular location and 
function. Despite the low homology shared between NV proteins, they conserve the same 
function. For all the reasons mentioned above, this thesis work aims to achieve the identification 
of the VHSV NV regions and mechanisms involved in the early shut-off of the host antiviral 
response carried out by the NV protein of VHSV. 
The main objectives of this thesis work are:   
1.  
To express and characterize VHSV NV (07.71) protein obtained in prokaryotic 
systems. 
2.  
To characterize the whole immune-related transcriptome profile induced by NV 
(07.71) in trout by using an immune-enriched microarray. 
3.  
To define the relationship among immune genes and pathways modulated in 
response to NV protein in trout. 
4.  
To correlate the VHSV NV (07.71) protein sequence with its function by using 
different fragments and to determine the effects of fragments on transcription of 
immune response genes. 
5.  
To study the functional implications of VHSV NV (07.71) variants compared to other 
novirhabdoviruses. 
6.  
To correlate the subcellular location of NV fragments and variants with function. To 
establish the differences with those NV proteins from other novirhabdoviruses. 
7.  
To develop a method for the detection of VHSV neutralizing antibodies in low 
amounts of blood and large number of fish samples. 
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PAPER I: Transcriptomic study of VHSV NV in trout 
 
TRANSCRIPTOME ANALYSIS OF RAINBOW TROUT IN RESPONSE TO NON-VIRION (NV) 
PROTEIN OF VIRAL HAEMORRHAGIC SEPTICAEMIA VIRUS (VHSV) 
 
El virus de la hemorragia septicémica viral (VHSV) infecta un gran número de especies 
acuáticas, siendo la trucha arcoíris uno de los salmónidos más afectados en cuanto a mortalidad. 
La proteína no-viriónica (NV) de VHSV no es esencial para la replicación del virus in vitro, pero sí 
lo es para la patogenicidad in vivo de VHSV. El objetivo de este trabajo es caracterizar en trucha 
los efectos que induce la NV en el transcriptoma de genes inmunes y de otros genes 
relacionados. Para el desarrollo del trabajo disponíamos de un microarray de trucha propio, 
diseñado y validado en nuestro laboratorio, capaz de reconocer un mayor número de genes 
inmunes que los microarrays comerciales. Inicialmente, se obtuvo la proteína NV de VHSV 
(07.71) para realizar los experimentos en trucha mediante inyección intraperitoneal. Se 
recogieron el bazo y el riñón cefálico de las truchas tratadas con NV y de las truchas control. Se 
extrajo el RNA total y sólo aquellas muestras que cumplían con los criterios de calidad se 
hibridaron con el microarray. El análisis estadístico de los datos obtenidos a partir del microarray 
permitió establecer los resultados mostrados en esta publicación, siendo estos novedosos y no 
habiendo sido descritos con anterioridad en la literatura. La proteína NV indujo una regulación 
negativa de la mayoría de los genes del microarray, si bien algunos se encontraban regulados 
positivamente. Entre los nuevos genes downregulados se encontraban genes clasificados como: 
VIG, factores de necrosis tumoral, receptores tipo-Toll, genes de procesamiento y presentación 
antigénica, interleuquinas, citoquinas, factores de transcripción, etc. Algunos de estos genes 
(stat1, jun y atf1) participaban en múltiples vías de activación (genes multipath), siendo 
regulados negativamente por la acción de la NV. En conjunto, todos estos resultados 
contribuyen a definir la función y efectos de la NV en trucha. De este modo, la extensa 
downregulación de genes inmunes inducida por la NV conllevaría la alteración del normal 
desarrollo de las respuestas inmunes innata y adaptativa, para así favorecer la replicación de 
VHSV. Además, este estudio pone de manifiesto el gran potencial de las metodologías “big data” 
para esclarecer, entre otros, los mecanismos moleculares implicados en la respuesta inmune a 
rhabdovirus. 
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PAPER II: Functional study of VHSV NV in ZF4 cells 
 
IDENTIFICATION OF THE FUNCTIONAL REGIONS OF THE VIRAL HAEMORRHAGIC SEPTICAEMIA 
VIRUS (VHSV) NV PROTEIN: VARIANTS THAT IMPROVE FUNCTION 
 
El gen NV está presente únicamente en las cuatro especies que componen el género 
Novirhabdovirus: IHNV, VHSV, HIRRV y SHRV. A pesar de la escasa homología inter-especie que 
comparten las proteínas NV, todas ellas (a excepción de la NV de SHRV) mantienen una función 
común encaminada a favorecer la replicación de los distintos virus. El objetivo principal de este 
trabajo era determinar y estudiar las regiones de la proteína NV de VHSV implicadas en su 
función. Además se estudió la implicación de una región concreta de la NV de VHSV en base a 
su homología con la NV de IHNV, dado que dicha región de la NV homóloga de IHNV tiene la 
función de transportar la proteína al núcleo para ejercer su función. También, se intentó 
establecer una correlación entre la localización subcelular y la función de la NV de VHSV, y así 
compararla con las proteínas NV de otros novirhabdovirus. Para ello, se ensayaron ocho 
fragmentos que cubrían diferentes secuencias lineales de la NV. Además, se generaron once 
variantes de NV con cambios únicos de sus aminoácidos correspondientes por alanina en las 
posiciones 28, 31 y de la 33 a la 41. La funcionalidad de estos fragmentos y variantes se 
estableció midiendo los niveles de expresión de transcritos de mx e il8 en células ZF4 
transfectadas con las construcciones de NV mencionadas. De los fragmentos ensayados, el 
fragmento N-terminal (F1) conservaba en mayor medida la función de inhibición de mx e il8, 
como la proteína NV completa. Por otro lado, el fragmento C-terminal (F2) perdía esta función 
porque aumentaba los niveles de mx e il8. Por su parte, las variantes NV36, NV39 y NV41 
mostraron una función de inhibición incrementada respecto a la proteína NV nativa. La 
localización subcelular de todas las variantes fue principalmente citoplásmica, al igual que 
ocurre con la NV nativa. Asimismo, el fragmento N-terminal que preservaba la función también 
tenía una localización citosólica. En conjunto, estos datos sugieren que la secuencia de la parte 
N-terminal de la NV de VHSV se correlaciona con una correcta localización y, a su vez, con la 
función. Además, estos resultados se compararon con la localización de las proteínas NV de 
otros novirhabdovirus (IHNV, HIRRV), estableciéndose homologías y diferencias entre ellas. El 
mapeo funcional de la NV de VHSV contribuye al estudio de la interacción de la NV de VHSV con 
su ligando PPM1Bb, para poder desarrollar futuros inhibidores o activadores del mismo. 
Finalmente, se pone de manifiesto que los polimorfismos de la NV pueden tener gran relevancia 
en la patogenicidad del virus (VHSV). 
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PAPER III: Optimization of neutralizing antibody assays 
 
OPTIMIZATION OF FIXED-PERMEABILIZED CELL MONOLAYERS FOR HIGH THROUGHPUT 
MICRO-NEUTRALIZING ANTIBODY ASSAYS: APPLICATION TO THE ZEBRAFISH/VIRAL 
HEMORRHAGIC SEPTICEMIA VIRUS (VHSV) MODEL 
 
La respuesta inmune adaptativa, basada principalmente en el desarrollo de anticuerpos 
neutralizantes, conlleva la supervivencia de los peces tras la infección por VHSV. La 
determinación de estos anticuerpos neutralizantes se realiza normalmente con volúmenes 
grandes de suero/plasma y mediante el contaje de unidades formadoras de placa (pfu) después 
de una incubación de células en monocapa con el virus. Alternativamente, se pueden reducir los 
tiempos de incubación, hacer una inmunodetección y contar los focos formados (ffu). No 
obstante, en truchas supervivientes a la infección por VHSV sólo se han detectado anticuerpos 
neutralizantes en el 40-50% de los peces estudiados y mediante ensayos de ffu. Además, las 
técnicas utilizadas hasta ahora requieren de pasos de lavado exhaustivos que conllevan la 
pérdida de células, un contaje de focos (ffu) aproximado y, en definitiva, una menor sensibilidad. 
En este trabajo se establece un nuevo método de seroneutralización para determinar la 
presencia de anticuerpos neutralizantes (IgM) de pez cebra (Danio rerio) en los peces 
supervivientes a los 2 meses post-infección con VHSV. El método combina el uso de volúmenes 
muy pequeños de plasma con una fijación-permeabilización específica (PERMFIX), y una 
detección por citometría de flujo. Para ello, se usaron células EPC dispensadas en placas de poly-
D-lisina, que se infectaron con una mezcla pre-incubada de plasma de pez cebra con VHSV. Tras 
la infección de la monocapa, las células se fijaron con formaldehído para disminuir su pérdida 
en los lavados. Después, se permeabilizaron las células con saponina, se incubaron con un 
anticuerpo monoclonal anti-N de VHSV, se levantaron las células con tripsina y se analizaron por 
citometría de flujo. Los resultados mostraron una correlación de r=0.99 entre el método ffu 
(tinción con DAB) y este nuevo método, y usando entre 200 ffu y 500 ffu de VHSV por 50000 
células EPC. Este método semi-automático, rápido y práctico permitió detectar anticuerpos 
neutralizantes anti-VHSV en 3 L de plasma en el 95.1% de los peces cebra supervivientes a la 
infección por VHSV. Así, esta nueva metodología podría analizar el suero/plasma de peces de 
diversos tamaños en condiciones estándar y determinar la presencia de anticuerpos 
neutralizantes anti-VHSV en los mismos, pudiendo ser aplicada a otros modelos virales. 
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Preface to discussion 
 
Non-virion (NV) proteins from different novirhabdoviruses are dispensable but necessary 
for an efficient virus replication and essential for virus pathogenicity, except for SHRV. These 
proteins are important to favour virus replication due to inhibition of immune response 
mechanisms and cell survival. Despite dissimilar primary NV protein sequences among VHSV, 
IHNV and HIRRV, these proteins produce analogous inhibitory effects. It is unknown whether 
this might be related to linear polypeptide sequences or due to a more complex tertiary protein 
structure, which is not shared by SHRV NV. In this part of the thesis, we discuss the contribution 
of different NV regions and individual amino acids from the region between the two first α-
helices (hinge region) to VHSV NV function and its subcellular location [261]. Here, it is also 
discussed the data obtained and presented in this thesis from rNV-driven transcriptional 
changes in rainbow trout, by using immune-targeted microarrays [257]. 
 
A. CELLULAR LOCATION OF NV PROTEINS AND ITS RELATION WITH FUNCTION 
 
The intracellular localization of NV proteins was first observed by immunofluorescence 
studies performed by Schütze et al. 1996 [97]. To this end, RTG and EPC cells were infected with 
VHSV and IHNV, respectively, and reaction with the corresponding anti-NV sera resulted in a 
diffusely distributed and perinuclear cytoplasmic fluorescence into the cells for VHSV but a 
nuclear staining for IHNV [97]. However, these observations were not pointed out by the 
authors. In addition, they observed a similar recognition pattern in infected cells when using 
polyclonal antibodies against virus, which was defined as a strong reaction pattern with coarse 
cytoplasmic granuloid structures in VHSV- or IHNV-infected cells [97]. 
Several years after those findings, through plasmid transfection of IHNV NV (PRT strain) 
fused to GFP, Choi et al. 2011 [238] also demonstrated that the NV protein of IHNV localizes to 
the nucleus and identified a nuclear location signal (NLS) sequence within the protein, consisting 
in four amino acid residues (32EGDL35) and located between the two first α-helices (termed by 
us “hinge region”), as responsible for its nuclear localization. This NLS was also demonstrated to 
be essential for a suitable function of the protein and viral replication [238]. Recently, other 
authors generated a recombinant IHNV virus with a NV-ΔEGDL gene. This rIHNV-NV-ΔEGDL gave 
rise to lower pathogenicity, and hence viral titers, and also more interferon and IL-6 levels in 
host compared to wild-type IHNV [248]. Therefore, it is well established the nuclear location of 
IHNV NV. Similarly, we have confirmed the nuclear location of IHNV NV from different strains, 
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PRT strain (data not shown) and Oregon69 strain (Figure 6, Paper II), and determined that the 
NV of HIRRV is also located at nucleus and contains a similar NLS motif at the hinge region. Even 
though the amino acid sequence of the NLS is highly conserved among IHNV strains (especially 
amino acid residues 33GDL35), the responsible NLS sequence for HIRRV NV nuclear location 
differed from the former ones (31DDGKI35 for HIRRV NV) [261].  
In the present work, we have also described a cytoplasmic location pattern for VHSV NV 
07.71 (Figure 6, Paper II), with certain perinuclear accumulation in a similar way to that observed 
by Schütze et al. 1996 for VHSV Fil3 strain [97]. The comparative sequence analysis between the 
hinge regions of VHSV and IHNV NV proteins showed very few identities, suggesting the lack of 
a canonical or non-canonical NLS compared to IHNV NV and HIRRV NV. As an approach, we 
carried out the insertion of the NLS (EGDL motif) of IHNV NV from PRT strain into the hinge 
region of the VHSV NV 07.71, between residues LNCDF and DRSD after amino acid 37, but this 
modification was not enough to redirect VHSV NV-EGDL to the nucleus, thus, remaining at 
cytoplasm unlike IHNV NV PRT.  
Very recently, it has been described that both NV from VHSV and IHNV interact with protein 
phosphatase, 1Bb (PPM1Bb), which is a member of the PPC2 family and which dephosphorylates 
TBK1 [258]. Nuclear (IHNV) and cytosolic (VHSV) NV proteins seem to interact with PPM1Bb in a 
different manner; VHSV NV recruits PPM1Bb around mitochondria to dephosphorylate TBK1, 
and further interferes with the retinoic acid inducible gene-I (RIG-I) response, whereas IHNV NV 
could bind to PPM1Bb around mitochondria and nucleus, acting on nuclear substrates different 
from TBK1 for inhibiting RIG-I response [258]. 
Finally, in the case of snakehead rhabdovirus (SHRV) NV protein, we also observed a 
cytoplasmic location for the NV (unpublished data). Nevertheless, this fact could not be 
correlated with any function (Figure 4A, Paper II), which is still unknown for NV of SHRV [262], 
nor the higher degree of identity among VHSV and SHRV NV proteins (23 % of identity, see C.1 
section) compared to other novirhabdoviruses. On the other hand, dissimilarity is not a good 
predictor for function because IHNV NV and VHSV NV only share 15%-16% of identity and they 
both have conserved the inhibitory function described for NV proteins. Regarding whole 
genome homology, identity values are comparable among novirhabdoviruses, since the genome 
comparison of Great Lakes VHSV strain (MI03GL) with SHRV exhibits a 62% of identity, whereas 
whole genomes from IHNV and HIRRV compared to that of VHSV showed a 56% of identity [99].  
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B. VHSV NV REGIONS INVOLVED IN FUNCTION AND LOCATION 
As previously discussed, the peptide identified as a nuclear location signal (NLS) sequence 
within the region located between the two first α-helices (termed by us the “hinge region”) in 
the IHNV NV (PRT) demonstrated to be very important for IHNV NV location and function [238, 
248]. Given that this NLS is mapped at this site within IHNV NV molecule and the homologous 
VHSV NV region could be important for function, we carried out functional studies using VHSV 
NV mutants and fragments to determine their location and activity (Figures 1 and 2, Paper II). 
No previous similar studies were carried out with VHSV NV protein. The results obtained 
suggested that tertiary structure is important for NV function since F1 retained its ability to 
inhibit mx and Il8 in zebrafish (ZF4) cell line, being F1 the fragment with more α-helixes (Figure 
3, Paper II). On the contrary, F2 fragment lost the capacity to inhibit mx and il8, being F2 the C-
terminal fragment with -sheets (Figure 3, Paper II). The N-terminal part of NV (i.e.: fragment 
F1) induced a similar mx and il8 modulation to wt-NV and also shared the same cytoplasmic 
location. Fragments F3 to F8, containing at least one of the two first α-helices and/or the hinge 
region, could be enough for maintaining an analogous activity to the complete NV but not the 
subcellular distribution (Figures 1 and 3, Paper II). Thus, fragment F6 induced similar mx and il8 
levels to those of F1 and wt-NV but did not share the same location pattern (Figures 3 and 8, 
Paper II), being more diffusely distributed in the nucleus and cytoplasm. This data suggests that 
the third -helix absent in F6 could be important for a better tertiary structure and a suitable 
location. The NV function has been related to its location and interaction with mitochondria 
[258]. More studies are needed to confirm that F1 but not F6 could interact with mitochondria. 
On the other hand, the C-terminal part of NV (i.e.: fragment F2) plays an unknown role in the 
cell; it upregulated mx and il8 transcript levels when compared to whole NV and did not have 
the characteristic cytoplasmic location pattern of the NV protein and the F1 fragment [261]. 
Altogether, our data suggested that F1, and not shorter N-terminal fragments nor F2, 
maintained a proper cytosolic location for a possible and suitable interaction with PPM1Bb in 
the close vicinity of mitochondria. This would need to be confirmed in future experiments. 
In order to study the contribution of amino acids from the hinge region to mx- and il8-
induced transcript levels and location, we studied eleven VHSV NV-derived mutants at positions 
28, 31 and 33-41 (Figure 2, Paper II), changing each corresponding amino acid to alanine. These 
amino acid positions were mainly chosen based on the existence of conserved amino acid 
residues into the VHSV NV protein of different strains (07.71 and Fil3) and shared amino acids 
between NVs from different novirhabdoviruses (VHSV and IHNV).  
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With regard to cellular location, VHSV NV 07.71 and all NV mutants studied exhibited a 
cytoplasmic distribution and shared this characteristic with VHSV NV Fil3 strain, as discussed 
above. Surprisingly, while mutants NV28 (D28A), NV31 (N31A), NV33 (L33A), and NV37 (F37A) 
induced similar mx and il8 levels to wt-NV, the mutants NV36 (D36A), NV39 (R39A), and NV41 
(D41A) induced a stronger mx and il8 downregulation than wt-NV (Figure 4, Paper II). The later 
data could suggest a better stabilization of the NV molecule in those three mutants and an 
improved interaction with its molecular target PPM1Bb that would induce a stronger TBK1 
dephosphorylation, which in turn would lead to a lower expression of mx and il8 transcript 
levels. Among the available VHSV NV amino acid sequences, there is no alanine at neither of the 
positions changed; residues at positions 36 and 39 are conserved whereas amino acids are 
variable at position 41 (aspartic acid or glutamic acid). It is interesting to note that a mutation 
incidentally conducting alanine at positions 36, 39 or 41 in the NV (07.71) protein might produce 
a more pathogenic VHSV strain (Table 1, Paper II). On the other hand, we obtained three-
dimensional models of the wild-type VHSV NV 07.71 protein, and mutants NVD36A, NVR39A, 
and NVD41A (by using 3Dpro software, Baldi group server, http://scratch.proteomics.ics.uci.edu). 
These predicted structures did not show any common molecular characteristic for correlating 
with their improved function (Figure 5, Paper II).  
On the other hand, certain NV-derived mutants (N34A, C35A, D38A and S40A) lost their 
ability to downregulate mx, but not il8, compared to the wt-NV protein (Figure 4, Paper II). 
Altogether, these data suggest that a single mutation in the NV could lead to a loss or an increase 
of function that would impact the virulence phenotype of the virus. In that sense, recently 
Baillon et al. 2017 [263] observed that various attenuated isolates of VHSV naturally bear a 
serine at position 116, except HRV2 isolate that despite bearing serine maintains its virulence. 
They replaced the arginine by serine at position 116 (R116S) in NV 07.71 and generated a virus 
by reverse genetics. This rVHSV NV (R116S) derived from a virulent VHSV strain was highly 
attenuated and those surviving fish were almost completely protected (80% survival) from a 
challenge with the wild-type VHSV. Therefore, these results showed that the presence of serine 
at position 116 affects to NV stability or structure for the correct function of NV 07.71. However, 
HRV2 isolate is virulent and naturally bears S116, suggesting that other amino acids along the 
protein are important for maintaining correct function. 
Finally, further research on different VHSV NV proteins using reverse genetics is needed to 
confirm whether the same mutations (e.g. D36A, R39A, and D41A) and/or other positions would 
lead to an improved inhibition similar to that observed in this study with VHSV NV 07.71 or the 
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opposite. In addition, future studies would help to clarify the mechanisms implied in the 
interaction of the wt-NV and mutants with PPM1Bb. 
Despite the different primary protein sequences among IHNV and VHSV NV proteins, here 
we demonstrated that the VHSV NV homologous region (hinge region) is also important for 
function, despite the absence of NLS. 
 
C. INTERFERENCE OF VHSV NV WITH THE HOST IMMUNE RESPONSE 
 
The NV protein of VHSV has been implicated in the interference of some host innate 
mechanisms in vitro, but little is known about the transcriptional changes induced by the protein 
in vivo. For this purpose, trouts were intraperitoneally injected with soluble recombinant NV 
(rNV) and the transcriptome changes induced by the protein were analysed at 48 h post-
injection (Figures 1 and 2, Paper I). Overall, our main results showed that rNV induced the 
inhibition of multiple innate and adaptive immune-related genes (Figure 3, Paper I). Although 
adaptive immune response begins later than the innate and the duration of the experiment, 
these results could be explained by the observed downregulation of some innate genes involved 
in triggering adaptive immune responses such as interleukins, interferons and transcription 
factors. The loss of the innate immune response and the delay of the adaptive immune response 
induced by the rNV protein would favour viral replication at least during the early stages of VHSV 
infection in a context of weak antiviral state. To our knowledge, this is the first report suggesting 
most important possible rNV ligands and describing extensive transcriptional in vivo profile 
changes induced by the rNV protein from any novirhabdovirus [257]; and probably has been 
taken as a reference for further studies on NV targets [258]. 
 
1. Confirming previous results of VHSV NV 
 
Gene expression changes in rainbow trout modulated by soluble rNV confirmed previous 
results on interferon (ifn) and ifn-related genes (mx) [199, 264], caspase-mediated apoptosis 
[237] and TNF-mediated NF-kB activation, increasing the confidence in the rest of the novel data 
obtained from the immune-targeted microarray. 
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a. NV inhibits the IFN system 
 
Interferons (IFNs) are the hallmark of vertebrate innate immunity to viruses. They belong to 
the cytokine family and can be classified into three families in mammals (type I IFNs, which 
include IFNα and IFN-β, type II or IFN-γ, and type III or IFN-λ) based on their structural and 
functional properties, and on their receptors [265]. Both type I and type III IFNs are strongly 
induced by viral infections and play a major role in the early innate response against viruses 
[265]. In contrast, type II IFNs (IFN-γ) are immunoregulatory cytokines also present in fish [266], 
with key roles in both innate and adaptive immunity [265]. 
Although fish IFNs have been often compared to type I mammalian IFNs, their expression is 
subject to an additional level of regulation [267]. Fish IFN promoter is typically made of two 
regions, and an alternative use of initiation of transcription leads to different transcripts. Upon 
viral infection, an alternative IFN isoform with an effective signal peptide is activated (secreted 
isoform), while the normal promoter usage leads to the expression of a non-secreted isoform in 
absence of stimulation [268] [185] [203]. Nevertheless, while the function of the long transcripts 
leading to non-secreted IFN was initially elusive [185], it was later observed that their 
overexpression leads to induction of orthomyxovirus resistance gene (mx) and to a protection 
against viral infection [269]. As overexpression of both intracellular IFNs and receptors leads to 
STAT signaling (JAK/STAT pathway) and induction of resistance to viral infection, it is proposed 
that they act as a partly constitutive cellular system of antiviral defence [269]. 
Mammalian type I IFNs bind the IFN-alpha/beta receptor subunit 1/2 (IFNAR1/IFNAR2) 
complex, and signal through the JAK/STAT pathway involving Jak kinases Jak1 and Tyk2 and STAT 
transcription factors (STAT-1 and -2, principally). Cellular response to IFN then consists of the 
up-regulation of a large number of genes, named IFN stimulated genes (ISG). While some ISG 
are modulators of the signaling pathways upstream or downstream of IFN itself (e.g. via IRF1), 
others ISG have a direct antiviral activity, such as Mx, illustrating the diversity of the cellular 
pathways triggered by viral infections and the functional complexity of type I IFNs [265, 267]. 
This IFN I promotion of an antiviral state through ISG such as Mx has been used to monitor IFN 
activity in trout [253] and has also been considered as a marker of the inhibitory activity of NV 
in this thesis [261]. 
On the other hand, MX proteins are large GTPases involved in intracellular membrane 
remodelling and intracellular trafficking [270] that have been cloned and characterised in many 
fish species [264, 267]. However, evidence for antiviral activity has only been established for Mx 
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proteins from Japanese flounder and Atlantic salmon [271, 272]. In rainbow trout, the target of 
our study, three different Mx genes (mx1, mx2, and mx3) have been previously cloned and 
characterized by Trobridge et al. 1995, 1997 [273, 274]. Over-expression of Mx in rainbow trout 
cells did not inhibit IHNV infection [273]. However, Mx was up-regulated during the early 
interferon response after DNA vaccination against VHSV [85], which was correlated to early 
protection [214]. Interestingly, different expression patterns were found for the three Mx 
isoforms after VHSV infection or stimulation with poly I:C, depending on the tissues, which 
suggested different regulation pathways [264].  
The importance of IFN system has also been reflected in our study, given that based on the 
modulation of these genes (mx, ifn or isg genes) we chose the most suitable control (PolyH) to 
study the effects of rNV. In this work (Paper I, [257]), we found multiple probes of type-I 
interferon genes (ifn1-5) and ifng downregulated by rNV as well as all the myxovirus resistance 
GTPase genes (mx1–mx3) (Figure 4, Paper I). Our results confirmed previous comparative 
studies between wild-type and NV knockout VHSV in which demonstrated that NV protein may 
downregulate host ifn1/mx transcriptional levels during in vitro infection of cyprinid-derived cell 
lines (EPC) and in vivo infection of olive flounder, suggesting that NV interferes with IFN defences 
to favour VHSV replication [251]. In addition, Choi et al. 2011 [238] observed similar effects in 
the virus-induced IFN response in vitro but with the NV of IHNV, and Wu et al. 2018 observed 
similar data with a recombinant IHNV expressing a NV without NLS motif (EGDL peptide) in 
vivo [248]. Although IHNV and VHSV NV proteins do not share any significant identity, Thoulouze 
et al. 2004 [240] showed that both NV proteins play a similar role since the replacement of IHNV 
NV by that of VHSV, rIHNV-NVVHSV, produced the same replication levels in vitro as in the wild-
type IHNV, probably via inhibition of host IFN system as IHNV NV does [238]. Because signal 
transducer and activator of transcription (STAT1) is a cytoplasmic latent transcription factor that 
becomes activated by some IFNs (i.e. IFNγ and IFN1) and binds to specific transcription factor 
binding sites (TFBS) to increase IFNs and IFN-related genes expression (such as mx), the 
downregulation observed suggests that NV not only interferes in vivo with the initial 
inflammatory and antiviral response to favour VHSV replication but also with the adaptive arm 
of immunity (i.e. IFNγ). 
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b. NV inhibits apoptosis 
Apoptosis, or programmed cell death, is an important physiological process for host defense 
against viral infection carried out by caspases, and it usually occurs at the early stage of viral 
infection, thus limiting viral propagation [275, 276].  
Many members of the Rhabdoviridae family are known to induce apoptosis. In case of 
novirhabdoviruses, it was shown that in vivo and in vitro infection with VHSV [237, 277-279] and 
in vitro infection with IHNV [250] results in extensive induction of apoptosis and that matrix (M) 
protein of novirhabdovirus would be involved in that induction [138-140] 
As with other viruses, VHSV suppresses or evades components of the host antiviral 
responses in order to propagate. To overcome host resistance, many viruses carry antiapoptotic 
factors to inhibit apoptosis (e.g. influenza virus, hepatitis C virus, etc.). Studies based on NV-
deficient and NV-knockout recombinant viruses have suggested that NV protein (and not the 
gene or the mRNA) suppresses apoptosis at early stage of infection (before 24 hpi) in cell culture 
[237, 250]. These recombinant viruses caused greater apoptotic effects than wildtype (rVHSV), 
as shown by stronger DNA laddering [237, 279], higher activity of caspases (initiator caspases 8 
and 9, and effector caspase 3 were significantly induced at 16-20-24hpi) [237] and sensitivity to 
apoptotic inducers (Actinomycin D) [237, 279]. Similarly to Ammayappan 2011, we observed 
downregulation of caspases 9 and 3 by rNV injection in trout, and also described new caspase 
transcripts downregulated such as casp1a and casp6 [257] (Figure 4, Paper I). Moreover, this 
antiapoptotic function of NV has been demonstrated to be restored by the NV of other related 
novirhabdoviruses despite the low homology exhibited between them [237]. 
It is very interesting that novirhabdoviruses produce of a large amount of matrix (M) protein, 
which induces apoptosis, and at the same time express catalytic amounts of NV protein to 
suppress apoptosis. According to Ammayappan and Vakharia (2011) [237], one possible 
explanation is that NV protein is produced in very small amounts to prevent early apoptosis 
(lengthen the time for viral replication in the cells) and is not produced enough to thwart late 
apoptosis caused by M protein, which would facilitate the viral release and dissemination. 
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c. NV suppresses TNFα-mediated NF-kB activation 
 
Nuclear factor-kB (NF-kB) plays a pivotal role in immediate early immune response to 
pathogens, in promoting inflammation and in regulation of cell survival, and its activation is a 
key step in TNFα-mediated immunomodulatory pathways. NF-kB exists as an inactive 
cytoplasmic form by binding to its inhibitory protein, IkBα. Upon stimulation, IkBα is 
phosphorylated by kinases and subsequently degraded by the proteasome, which allows nuclear 
translocation of NF-kB and activation of NF-kB target genes including proinflammatory and 
antiviral cytokine genes such as tumor necrosis factor (tnf)-α, among others (e. g.: il1b and il8) 
[254]. On the other hand, TNF-α is a proinflammatory cytokine produced by immune cells in 
response to pathogens that can induce either NF-kB mediated survival or apoptosis, depending 
on the cellular context [280], and whose antiviral activity has been well demonstrated in various 
viruses in mammals [254]. However, the role of TNF-α in fish viral infection still remains 
uncertain despite the fact that Roca et al. (2008) reported that this cytokine facilitated in vitro 
replication and increased in vivo susceptibility to spring viremia of carp virus (SVCV) [255]. 
In our study, we found downregulated by rNV most of members of the tumor necrosis factor 
(tnf) family, which promote inflammation, including tumor necrosis factor alpha (tnfα) that is 
one of the most important inducers of systemic inflammation (Figure 5, Paper I). Moreover, we 
found downregulated the p100/p52 transcription factor (nf-kb2) (Figure 4, Paper I). These 
findings altogether support the results obtained by Kim and Kim (2013), who suggested that NV 
of VHSV suppresses TNF-α-mediated NF-κB activation in vitro [254]. Furthermore, they 
generated a NV gene knock-out recombinant VHSV (rVHSV-ΔNV-EGFP), which induced 
significantly higher NF-κB activity in EPC cells than wild-type VHSV, suggesting that VHSV 
adopted a strategy to suppress early activation of NF-κB in host cells through the NV gene [254]. 
 
2. Novel effects of VHSV NV  
 
The immune system is a set of cellular and humoral components to defend the body against 
foreign microorganisms, among other threats. As in mammals, the fish immune system is also 
divided into innate and adaptive, both in turn divided into cell mediated defense and humoral 
factors, although today it is known that these two systems work together to trigger defense 
processes [265].  
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The innate system includes all components present in the body before the appearance of 
the pathologic agent, as the first line of defense that acts faster than the adaptive, and is able 
to recognize conserved molecular structures common to pathogenic microorganisms (PAMPs) 
such as viral RNA molecules, among others, through their interaction with specific receptors 
(TLRs). These mechanisms of recognition may lead directly to successful removal of pathogens, 
for instance by phagocytosis, or may trigger additional protective responses through induction 
of adaptive immune responses. Genes of the innate immune system have a diverse array of 
functions. For example, some genes promote phagocytosis (e.g.: TLR-inducible genes), and 
others, stimulate and help guide the migration of cells and further direct the immune response 
(e.g.: cytokines and chemokines) [265].  
In this work, we not only confirmed previous results regarding TNF-α-mediated NF-kB 
activation, mx, the downregulation of some interferons and the anti-apoptotic role of NV but 
also described a plethora of new immune innate and adaptive response genes differently 
expressed compared to the polyH control [257] (Paper I, and Table 5). Among these genes, we 
found novel and numerous innate genes expressed downwards such as interferons, tumor 
necrosis factors, toll-like receptors, interleukins, chemokines and transcription factors (Table 5). 
However, a few genes were found upregulated, and in some cases these genes are inhibitors of 
inflammation (such as il20 and il10), favouring the shut-off of the immune response. Moreover, 
downregulation of TLR genes by NV showed that immune response is also hampered at 
recognition level.  
Among transcription factor genes, we detected some of them downregulated such as stat1, 
jun, atf1, stat3, stat5, tbx21, p100, cebp, srcap. STAT factors play a key role in important 
pathways promoting interferon expression (JAK/STAT) or regulating other signaling pathways 
(stat3, stat5). JUN and ATF1 form a dimer to give rise AP1, which targets DNA response elements 
leading to many immunological effects including those related to tnf and tnf-related genes. NV 
downregulated NF-kB subunit p100 (p52) and this fact seriously affects proliferation and 
immune response targets at nucleus. In addition, there is an accumulative effect because CD40 
(tnf5 gene) is also downregulated diminishing p100 processing to p52 [281]. Cebp gene, also 
known as nuclear factor of interleukin 6, is involved in immune and inflammatory responses, 
among other processes. Tbx21 protein is a Th1 cell-specific transcription factor that controls the 
expression of the hallmark Th1 cytokine, interferon-gamma (IFNg). Srcap codes for a helicase 
that acts as a coactivator for CREB-mediated transcription, steroid receptor-mediated 
transcription, and Notch-mediated transcription. These transcription factors affect the low 
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expression of immune response genes that cannot close the regulatory circle (i. e.: IFN-STAT1-
IFN) or regulate other pathways appropriately. 
On the other hand, the adaptive system recognizes foreign structures by means of two 
cellular receptors (BCR and TCR) and is highly regulated by several mechanisms. Adaptive 
immunity generally starts days after infection and is capable of recognizing specific protein 
motifs of peptides, which leads to a response that increases in both speed and magnitude with 
each successive antigen exposure and produces immunological memory, the basis of vaccine 
development. The main effector cells of the adaptive immune response are the lymphocytes, 
specifically B and T cells. When B cells are activated, they are capable of differentiating into 
plasma cells that can secrete antibodies. Upon activation T cells differentiate into either helper 
T cells or cytotoxic T cells. Helper T cells are capable of activating other cells of the adaptive 
immune response such as B cells and macrophages, while cytotoxic T cells upon activation are 
able to kill cells that have been infected [282]. NV induced the downregulation (and certain 
upregulation) of humoral and cellular adaptive immune response genes such as the antigen 
presentation machinery, cluster differentiation antigens and some interleukins and chemokines, 
macrophage-related genes and the classic complement pathway (Table 5). Regarding humoral 
adaptive genes we found downregulated il2 and ifng among others. Within cellular adaptive 
genes those found downregulated in trout are cd79a (forms heterodimer with BCR), antigen 
processing and presentation molecules (tap, lmp2, tapbp), cd2 (partipates in adhesion T-
lymphocytes and APC), cd3 (is part of TcR), and cd28 (co-stimulatory molecule in antigenic 
presentation). Moreover, NV also downregulated many genes which connect innate with 
adaptive immunity such as type I ifn, tnfa, il12, il15, and il1b. 
The vast downregulation (and certain upregulation) of novel innate immune-related genes 
and adaptive immune-related genes induced by rNV (Table 5) suggests that NV impairs the 
normal development of the host innate immune response and also delays the start of adaptive 
responses, interfering with the antiviral state and inflammatory response of host cells and 
enhancing viral replication. All these inhibitory effects disappear when using recombinant 
viruses in different fish models. So, in vivo protection has been reported for VHSV challenge with 
NV knockout VHSV in olive flounder [42] and for IHNV challenge with NV knockout [240] and 
NV-ΔEGDL [248] IHNV for trout as live-attenuated vaccine candidates in a dose dependent 
manner.  
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Table 5. Novel modulation (downregulation or upregulation) of statistically significant immune-related 
genes induced by the recombinant NV protein (rNV) of VHSV and the possible effects of this gene 
modulation on host immune response. Interesting immune-related genes downregulated or upregulated 
in this study that were not statistically significant are included and marked in red (Figures 4 to 7, Paper I).  
 
NOVEL IMMUNE GENE MODULATION INDUCED BY NV (VHSV) 
REGULATION GENES EFFECTS ON IMMUNE SYSTEM 
Downregulation 
 
IFN and IFN-related 
(ifn1, ifng, irf1, irf2, irf10) 
Interference with the host antiviral state enhancing 
viral replication 
VHSV-induced genes (vigs) Suppression of early host responses 
Caspases (Casp) 
(Casp1a, Casp6, Casp9) 
Inhibition of early apoptosis favouring viral 
replication 
Transcription factors (TF) 
(Stat1, jun, atf1, stat3, stat5, 
tbx21, p100, cebp and srcap) 
Low expression of proteins related to immune 
system 
TNF-related 
(tnfa, tnf5 or CD40, tnf10, tnf11, 
tnf13, tnfr and ltb2) 
Inhibition of inflammatory responses 
TLR-related 
(tlr1, tlr3, tlr7 and tollip1 and 2) 
Inhibition of viral RNA detection 
APM genes 
(tapbp, tap1 and 2, lmp2 and 
b2m) 
Impairment of appropriate processing of pathogen 
antigens, delaying the adaptive immune response 
CD antigens 
(cd2, cd4, cd8, cd28, cd3e, cd79a 
and cd200) 
Adaptive immune response delay, except for cd200 
(NK immunosuppression) 
IL-related 
(il1b, il2, il8, il15, il16, il17d, il29 
and ilr3) 
Downregulation of nfkb and therefore interference 
of the immune response in many other pathways. 
Inhibition of inflammatory response. 
MA-related genes 
(cd11, pbef, cdh, mcsf and 
nramp) 
Interference with phagocytosis, apoptosis and 
antigen processing and presentation. 
Chemokine (CK) genes 
(ck2,ck6, ck10, ck12, socs, cc, cxc, 
cxcd1 and 2) 
Interference with inflammation and correct 
triggering of the systemic immune response 
Complement (CO)-genes 
(prf, c1q, cr1 and c4) 
Delay antibody and/or cellular-mediated responses 
Upregulation 
CD antigens 
(cd33, cd97, cd209) 
Stimulation of the host immune response like any 
other protein antigen 
IL-related genes 
(il17a and il17c, il10, il20) 
Inhibition of inflammatory responses 
MA-related genes 
(csf1) 
Interference with phagocytosis, apoptosis and 
antigen processing and presentation. 
Chemokine (CK) genes 
(ck11, ckb14, ccr5 and cxcr) 
Interference with inflammation and correct 
triggering of the systemic immune response 
Complement (CO)-genes 
(c3a, c3.3, cfi, h1) 
Delay antibody and/or cellular-mediated responses 
and also possible host compensatory mechanisms 
 
 
The novel data presented in this work (Paper I) [257] improve our knowledge of the 
immunosuppression mechanisms used by the NV protein of VHSV and could explain much better 
than before the protection induced by NV knockout novirhabdoviruses as due to the lack of an 
extensive inhibition of host early immune gene responses. 
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3. Multipath genes reveal possible VHSV NV targets 
 
The potential of multipath genes to suggest functional studies had been used previously to 
investigate the effects of spring viraemia virus (SVCV) infection on zebrafish and suggest 
preventive drug candidates [283]. This analysis is an approach to detect genes involved in the 
immune response in the multiple and complex existing pathways, helping to establish close 
relationships among genes and possible targets. To test for differentially expressed multipath 
genes, microarray genes were first classified into 74 rainbow trout immune-related pathways. 
In order to do that, the list of accession numbers of the microarray genes was first compared 
with the rainbow trout accession numbers obtained by manually searching their corresponding 
orthology in immune-related human pathways actually present in public databases. The 
classified genes were then systematically searched for genes (i) common to at least six immune-
related pathways [283], (ii) with differential expression folds <0.66 or >1.5 and (iii) significantly 
different from one of the 0.66/1.5 thresholds (p≤0.05).  
Results obtained in the multipath analysis showed 14 genes (Table 1, Paper I) that 
accomplished the selection criteria. Stat1 is the multipath gene more downregulated that 
participates in more pathways (n=27), followed in the number of pathways by jun and atf1. 
Other important downregulated gene is il1b although is participating in 8 immune pathways. 
Stat1 participates in important pathways such as chemokine signaling pathway, JAK-STAT 
signaling pathway, and Toll-like receptor signaling pathway (see all in 
https://www.genome.jp/dbget-bin/www_bget?ko:K11220). Jun and atf1 participate as 
transcription factors in many pathways (see all in https://www.genome.jp/dbget-
bin/www_bget?hsa:3725 and https://www.genome.jp/dbget-bin/www_bget?ko:K09053, 
respectively) leading to a reduced activity in gene transcription. Moreover, other genes detected 
suggest that apoptosis (casp6), interferon (ifn1, irf1, irf10, ifng) and tumor necrosis factor 
receptors (traf2, traf3) are implied in immune pathways affected by NV. Other genes common 
to more than 6 pathways were downregulated in microarray but not differentially expressed, 
for instance, p53, tnf6, il6, mhc2.daa, junb, if2a, myc, tgfb, il12b, il8, grb and irak4. Altogether, 
these data showed the wide downregulatory effects induced by NV and could led to establish 
relationships among genes and pathways in the immune response against NV and to help 
searching initiators in signaling cascade. 
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D. VHSV INFECTION AND THE MEASUREMENT OF NEUTRALIZING ANTIBODIES 
 
With the development of reverse genetics technology, numerous NV-deleted recombinant 
viruses have been obtained and assayed (see Table 4) observing that their pathogenicity in vivo 
is lower, reason why they have been considered to be used as live attenuated vaccines. This is 
partly due to the absence of negative effects in the host caused by the NV protein (absent in 
these recombinant viruses). The studies with these viruses have been carried out in different 
models of fish: zebrafish, rainbow trout, yellow perch and olive flounder (Table 4). In each study, 
fish survival was assessed after vaccination and further challenge, displaying a high survival of 
the fish treated with the recombinant viruses independently of the fish model.  
Surprisingly, in these studies, humoral immune parameters such as neutralizing antibodies 
against virus measured by seroneutralization assays have not been established yet. Neutralizing 
antibodies are directed against viral surface glycoproteins (G) and are an important component 
of the protective immune response of rainbow trout to VHSV [211]. This set of antibodies is 
measured by indirect diagnostic assays such as neutralization tests [284], among others (ELISA, 
etc). On most sampling occasions, antibodies were detected even when the virus was not, 
suggesting that these fish have survived a relatively recent VHSV infection. To date, however, 
studies on neutralizing antibodies have been infrequent due to lack of availability of reliable 
serological diagnostic tests. Consequently, it has been difficult to ascertain the proportion of 
wild fish that have been infected by VHSV and have survived. It has also been difficult to infer 
whether the virus persists in wild fish populations in postepizootic years. 
The standard techniques used normally require relatively large volumes of plasma (or 
serum) that are sometimes difficult to obtain. The work presented as part of this thesis (Paper 
III) report a seroneutralization technique that required minimum volumes of plasma (or serum) 
from fish and a semi-automated method for neutralizing antibody screening. These results could 
serve as a basis for future studies on vaccine effectiveness that want to delve into the antibody 
response to VHSV independently of the model used. These data would be important to correlate 
the presence of neutralizing antibodies with fish survival and the virus and virus-dependent dose 
used in the vaccine, as well as the long-term protection. Moreover, the incorporation of 
serological testing into current VHSV surveillance programmes would be useful to determine the 
immune status of populations and also to provide a more thorough understanding of virus 
distribution. 
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CONCLUSIONES 
 
1. La proteína VHSV NV 07.71 puede ser expresada en sistemas procariotas y posteriormente 
purificada para ser inoculada en truchas. Sin embargo, la NV tiende a precipitar y sólo una 
pequeña parte que permanece soluble puede ser utilizada para este fin.  
 
2. Por primera vez, se ha caracterizado en trucha el perfil transcriptómico de genes de 
respuesta inmune inducido por la NV a 48 horas post-infección (hpi). 
 
3. Algunos de los efectos de la NV observados en trucha confirmaron los efectos descritos 
previamente como son la regulación negativa de mx, ifn1 and caspasa 9 (casp9).  
 
4. Se han caracterizado en el transcriptoma de tejidos inmunitarios de trucha gran número de 
cambios nuevos inducidos por la NV en genes de respuesta inmune innata y adaptativa, la 
mayoría de ellos regulados negativamente.  
 
5. Entre los nuevos genes downregulados por la NV se encuentran genes de respuesta inmune 
innata relacionados con interferón (iip30, ipf35, iip2, gig2, irf7, irf10), factores de 
transcripción (jun, atf-1, stat1, stat3), factores de necrosis tumoral (tnfa, traf3) y sus 
receptores, receptores tipo Toll, interleuquinas, citoquinas, genes CD, complemento y otros 
genes co-estimuladores.  
 
6. Algunos genes de respuesta inmune adaptativa también estaban downregulados por la 
proteína NV, como son los genes del sistema principal de histocompatibilidad de clase II, y 
los de procesamiento y presentación antigénica (tap, lmp, b2m).  
 
7. En conjunto, estos datos mostraron que la NV induce una importante disminución de la 
expresión génica que no sólo lleva a un estado antiviral deficiente sino que también conlleva 
una comunicación ineficaz entre las respuestas inmunes innata y adaptativa.  
 
8. Las células de pez transfectadas con la NV de VHSV, IHNV e HIRRV presentan un efecto 
inhibitorio de la expresión génica de mx, estando las NVs implicadas en la patogenicidad. 
Estos son datos confirmatorios para VHSV e IHNV pero nuevos para HIRRV. Además, la NV 
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de SHRV no produjo la downregulación de mx sugiriendo que no es necesaria para la 
replicación del virus snakehead.  
 
9. Las variantes NVD36A, NVR39A y NVD41A aumentaron su capacidad inhibitoria sobre los 
transcritos de mx e il8 en comparación con la NV nativa. Estas variantes podrían ser más 
estables e interaccionar de forma más eficiente con su ligando, la fosfatasa PPM1Bb, la cual 
podría defosforilar en mayor medida TBK1 y, en consecuencia, conducir a mayor inhibición 
de las vías de señalización descendentes.  
 
10.  Se demuestra que la región bisagra de la NV de VHSV puede afectar a su función y que no 
contiene una señal de localización nuclear (NLS) como la definida para la NV de IHNV.  
 
11. Se ha mapeado la funcionalidad de la NV y ésta depende de la parte N-terminal de la NV (F1) 
y no así de la parte C-terminal (F2), aunque esta última parte podría conferir mayor 
estabilidad a la estructura terciaria de la proteína.  
  
12. La proteína NV nativa, y todas las variantes y fragmentos funcionales de la misma, se 
localizan en el citoplasma, mientras que el fragmento no funcional (F2, C-terminal) se 
localiza de manera difusa tanto en el citoplasma como en el núcleo. Así, existe una clara 
correlación entre el patrón de localización y la función.  
 
13. El desarrollo de una técnica de detección semi-automática de anticuerpos neutralizantes 
frente a VHSV en pequeños volúmenes de plasma permitiría su aplicación al estudio de la 
efectividad de las vacunas frente al virus, particularmente aquellas basadas en la deleción 
de la NV. 
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CONCLUSIONS 
 
1. The VHSV NV 07.71 protein can be expressed in prokaryotic systems and further purified to 
be injected in trout. However, NV tends to precipitate and only a small soluble amount can 
be used for this purpose. 
 
2. For the first time, it has been characterized in trout the immune transcriptome profile 
induced by NV at 48 hours post-infection (hpi). 
 
3. Some of the observed NV effects in trout confirmed those previously described such as: 
downregulation of mx, ifn1 and caspase 9 (casp9). 
 
4. The major immune-related transcriptome changes induced by NV are a plethora of new 
affected genes, mostly downregulated, from innate and adaptive immune response in trout. 
 
5. Among these new downregulated genes by NV are found innate immune response genes: 
interferon-related genes (iip30, ipf35, iip2, gig2, irf7, irf10), transcription factors (jun, atf-1, 
stat1, stat3), tumor necrosis factors (tnfa, traf3) and their receptors, Toll-like receptors, 
interleukins, cytokines, CD (cluster of differentiation), complement, and other co-
stimulatory genes.  
 
6. Adaptive immune response genes are also downregulated by NV protein: major 
histocompatibility complex class II genes, and antigen processing and presenting genes (tap, 
lmp, b2m). 
 
7. Overall, these data showed that NV induces an important gene shutdown not only leading 
to a weak antiviral state but also to a dysfunctional crosstalk between innate and adaptive 
immune response. 
 
8. Fish cells transfected with NV from VHSV, IHNV, and HIRRV exhibit an inhibitory effect of 
gene expression, downregulating mx among others and being NVs implied in pathogenicity. 
These are confirmatory data for VHSV and INHV but new for HIRRV. Moreover, NV from 
SHRV did not downregulate mx supporting that it is not necessary for snakehead virus 
replication. 
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9. Variants NVD36A, NVR39A and NVD41A improved their ability to downregulate mx and il8 
transcripts compared to wt-NV. These variants could have acquired more stability and 
improved interaction with its target the phosphatase PPM1Bb, which would 
dephosphorylate TBK1 in higher degree and subsequently would lead to stronger inhibition 
of downstream pathways. 
 
10. It is demonstrated that the hinge region of the VHSV NV can affect its function and that it 
does not contain a nuclear localization signal (NLS) as defined for the IHNV NV. 
 
11. NV functionality has been mapped out, and this rely on N-terminal part of NV (F1) rather 
than the C-terminal one (F2), even if this latter sequence could confer higher molecular 
stability to the tertiary structure of the protein. 
  
12. Wild-type NV, and all NV variants and functional NV fragments, are located in cytoplasm 
with the same pattern, whereas non-functional NV fragment (F2, C-terminal) is diffusely 
located in both cytoplasm and nucleus. Thus, there is a clear correlation between the 
location pattern and the function. 
 
13. The development of a semi-automatic assay to detect anti-VHSV neutralizing antibodies in 
low volumes of plasma blood samples could allow its application in future studies on vaccine 
effectiveness, particularly those based on NV deletion. 
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